Tag Archives: NUS

Top 5 Canadian Stocks To Watch For 2018

USD/CAD is trading at 1.2882, down 0.0027.

The pair continues to trade just above the lows of the session.

Statistics Canada reported that May manufacturing sales fell 1.0 percent versus rise of 1.0 percent in April.

Market chatter about global headline news and U.S. economic is making the rounds.

Posted-In: Canadian dollar USD/CADFutures Forex Markets

© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

 
Related Articles U.S. Dollar Index Little Higher, Core CPI Improves PNC Financial Q2 Earnings Top, Revenue Miss Expectations Superior Energy Price Target Raised 53% At Imperial Capital, Upgraded Goldman Sachs Sees 'Limited Upside' In Teva Regardless Of Acquisition Results

Top 5 Canadian Stocks To Watch For 2018: Safeway Inc.(SWY)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of small cap SUPERVALU now underperforming large cap Kroger Co (NYSE: KR) while shares of large cap Whole Foods Market, Inc (NASDAQ: WFM) and mid cap Safeway Inc (NYSE: SWY) appear to be back to where they started at:

  • [By Peter Graham]

    A long term performance chart shows shares of SUPERVALU underperforming the underperformance ofmid caps Whole Foods Market, Inc (NASDAQ: WFM) and Safeway Inc (NYSE: SWY). while large capKroger Co (NYSE: KR)had outperformed up until the last two years when performance has been more mixed:

Top 5 Canadian Stocks To Watch For 2018: ConocoPhillips(COP)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    The contract awards are for the jack-ups West Elara and West Linus with ConocoPhillips Skandinavia AS (COP) for work in the Greater Ekofisk area. The total additional backlog for the new contract awards is estimated to be about $1.4 billion, excluding performance bonuses.

  • [By WWW.KIPLINGER.COM]

    Spun off from energy producer ConocoPhillips (COP) a few years back, PSX has quickly become one of the downstream industrys biggest players. Refiners earn profits based on the difference between feed stock costs (Think oil and natural gas prices) and the price for refined products such as gasoline, jet fuel and heating oil. Those inputs remain low, and Phillips 66 is minting cash as a result.

  • [By Chris Dier-Scalise]

    Among the brands being sold were Alcoa Corporation (NYSE: AA) and Ford Motor Company(NYSE: F), which both paid out dividends in December. The financial and oil sectors also experienced a sell-off to finish 2016. Wells Fargo & Co (NYSE: WFC) and Citigroup Inc (NYSE: C) were net sold as each reached new year-to-date highs and investors unloaded ConocoPhillips (NYSE: COP) and Chevron Corporation (NYSE: CVX) as their prices normalized with the rise in the price of oil.

  • [By Jon C. Ogg]

    Things have improved handily from a year ago in the energy sector. Still, even with a pro-energy White House, things are far from perfect in the oil and gas sector. Now ConocoPhillips (NYSE: COP) is delivering great news to its shareholders.

Top 5 Canadian Stocks To Watch For 2018: Nu Skin Enterprises Inc.(NUS)

Advisors’ Opinion:

  • [By Craig Jones]

    Nu Skin Enterprises, Inc. (NYSE: NUS) is trading sharply higher on Friday, but options traders are buying puts in the name, said Jon Najarian. Traders were buying the June 50 puts and they paid around 6 percent for them, so they don't see much upside in Nu Skin Enterprises, explained Najarian. He followed the trade and he is planning to hold the position for a month.

  • [By Ben Levisohn]

    Citigroup’s Beth Kite calls Nu Skin Enterprises’ (NUS) earnings and guidance “awfully disappointing.” She explains why:

    “Frustrating” Describes 4Q15 & 2016 Guidance:Nu Skin (i) reported 4Q15 EPS of $0.62, 11 cents below consensus and us, and (ii) lowered 2016 EPS guidance, from $3.25-$3.40 to $2.40-$2.60.Nu Skin had three LTO’s in 4Q152 succeeded and 1 failed. The failure had far less to do with the product than with the sales strategy…

    Is Guidance Too Conservative or Is It Really This Bad? We get that Me failed to sell well in South Korea with the 12-month cartridge commitment. But given the strength in reps globally, the strength of Youth from its two LTOs in 2H15, and good results from Me when sold in Japan without the 12-month commitment, we wonder if guidance is aggressive to the downside. Indeed, the word “conservative” was said a lot by mgmt on the brief earnings call when describing guidance revisions.

    Maintaining Buy: While we now have less confidence in mgmt, from an external perspective, to forecast its results accurately, and from an internal perspective, to course correct quicklyi.e., why didn’t they drop the 12-month plan for Me in South Korea when it so obviously wasn’t workingwe are still confident in Youth & Me. The rep growth in South Asia/Pacific from Youth in 3Q led to better 4Q sales than we’d expected, Youth’s Americas LTO in 4Q drove lc sales up 26% YoY, and Me not only sold through in Japan in 4Q but also drove reps higher. We imagine that investors may have little patience or confidence in Nu Skin for a while, understandably. But the bar seems set fairly low now, so we are cautiously optimistic that Nu Skin can dig itself out of this hole as we go through 2016 and Me & Youth roll out more fully.

    Shares of Nu Skin have tumbled 13% to $27.31 at 2:11 p.m. today.

  • [By Scott Rubin]

    Stock gainers included Mercadolibre Inc (NASDAQ: MELI), up almost 14 percent, and Nu Skin Enterprises, Inc. (NYSE: NUS), which added 12 percent. The positive gains in both stocks were due to strong earnings reports. Shares of Liberty Interactive Group (NASDAQ: QVCA) plunged almost 22 percent on Friday due to disappointing sales growth in its fiscal second quarter. Pharmaceutical giant Bristol-Myers Squibb Co (NYSE: BMY) lost 16 percent after a disappointing study involving its Opdivo drug.

  • [By Roberto Pedone]

    Nu Skin Enterprises (NUS) is a direct selling company, which develops and distributes personal care products and nutritional supplements that are sold under the Nu Skin and Pharmanex brands. This stock closed up 5.4% at $92.96 in Monday’s trading session.

    Monday’s Volume: 2 million

    Three-Month Average Volume: 900,802

    Volume % Change: 85%

    From a technical perspective, NUS ripped higher here right above some near-term support at $85 with heavy upside volume. This move pushed shares of NUS into breakout and new 52-week-high territory, since the stock took out some near-term overhead resistance levels at $88.20 to $89.69. This move also pushed shares of NUS above the upper-end of its recent range that saw the stock trend between $82 to just above $89.

    Traders should now look for long-biased trades in NUS as long as it’s trending above support at $85 and then once it sustains a move or close above Monday’s high of $93.33 with volume that this near or above 900,802 shares. If we get that move soon, then NUS will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $100 to $105.

Top 5 Canadian Stocks To Watch For 2018: NRG Energy Inc.(NRG)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was NRG Energy, Inc. (NYSE: NRG) which rose over 5% to $22.20. The stocks 52-week range is $9.84 to $23.36. Volume was over 35 million compared to its average volume of 5.8 million.

  • [By Lisa Levin]

    Non-cyclical consumer goods & services sector was the top gainer in the US market on Wednesday. Top gainers in the sector included Cia Energetica de Minas Gerais CEMIG-ADR (NYSE: CIG), Companhia Paranaense de Energia (ADR) (NYSE: ELP), and NRG Energy Inc (NYSE: NRG).

  • [By Craig Jones]

    Pete Najarian said that there was a big options activity in NRG Energy Inc (NYSE: NRG). Traders were aggressively buying the October 26 calls. Around 6,000 contracts were traded in the first half of the session and they were paying 65 cents for them. The trade breaks even at $26.65 or more than 11 percent above the current market price.

Top 5 Canadian Stocks To Watch For 2018: Prestige Brand Holdings Inc.(PBH)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Castor believes the cash has disappeared into working capital, which has grown from 23% to more than 50% since 2008. Comparable company PrestigeBrand (PBH) uses 11%; Unilever(UL) and Colgate-Palmolive(CL) far less.

Top 10 Canadian Stocks To Buy For 2018

Investment company Forte Capital Llc buys Cummins Inc, Canadian National Railway Co, Maxim Integrated Products Inc, iShares Core U.S. Aggregate Bond, Colgate-Palmolive Co, DowDuPont Inc, NVIDIA Corp, Raytheon Co, Facebook Inc, Phillips 66, sells Vanguard Small-Cap, iShares TIPS Bond, iShares Russell 1000 Growth, E.I. du Pont de Nemours, iShares 7-10 Year Treasury Bond ETF during the 3-months ended 2017-09-30, according to the most recent filings of the investment company, Forte Capital Llc . As of 2017-09-30, Forte Capital Llc owns 158 stocks with a total value of $311 million. These are the details of the buys and sells.

New Purchases: CMI, CNI, MXIM, DWDP, NVDA, RTN, IPGP, PSX, SCHA, NOVT, Added Positions: BIV, BSV, AGG, CL, VOE, FB, IWP, MO, DLR, SIX, Reduced Positions: RPG, VBR, VBK, IWF, MA, GILD, CSCO, IEF, MKTX, LOW, Sold Out: VB, TIP, DD, LUK, PNRA,

For the details of FORTE CAPITAL LLC ‘s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=FORTE+CAPITAL+LLC+

Top 10 Canadian Stocks To Buy For 2018: Nu Skin Enterprises Inc.(NUS)

Advisors’ Opinion:

  • [By Scott Rubin]

    Stock gainers included Mercadolibre Inc (NASDAQ: MELI), up almost 14 percent, and Nu Skin Enterprises, Inc. (NYSE: NUS), which added 12 percent. The positive gains in both stocks were due to strong earnings reports. Shares of Liberty Interactive Group (NASDAQ: QVCA) plunged almost 22 percent on Friday due to disappointing sales growth in its fiscal second quarter. Pharmaceutical giant Bristol-Myers Squibb Co (NYSE: BMY) lost 16 percent after a disappointing study involving its Opdivo drug.

  • [By Ben Levisohn]

    Citigroup’s Beth Kite calls Nu Skin Enterprises’ (NUS) earnings and guidance “awfully disappointing.” She explains why:

    “Frustrating” Describes 4Q15 & 2016 Guidance:Nu Skin (i) reported 4Q15 EPS of $0.62, 11 cents below consensus and us, and (ii) lowered 2016 EPS guidance, from $3.25-$3.40 to $2.40-$2.60.Nu Skin had three LTO’s in 4Q152 succeeded and 1 failed. The failure had far less to do with the product than with the sales strategy…

    Is Guidance Too Conservative or Is It Really This Bad? We get that Me failed to sell well in South Korea with the 12-month cartridge commitment. But given the strength in reps globally, the strength of Youth from its two LTOs in 2H15, and good results from Me when sold in Japan without the 12-month commitment, we wonder if guidance is aggressive to the downside. Indeed, the word “conservative” was said a lot by mgmt on the brief earnings call when describing guidance revisions.

    Maintaining Buy: While we now have less confidence in mgmt, from an external perspective, to forecast its results accurately, and from an internal perspective, to course correct quicklyi.e., why didn’t they drop the 12-month plan for Me in South Korea when it so obviously wasn’t workingwe are still confident in Youth & Me. The rep growth in South Asia/Pacific from Youth in 3Q led to better 4Q sales than we’d expected, Youth’s Americas LTO in 4Q drove lc sales up 26% YoY, and Me not only sold through in Japan in 4Q but also drove reps higher. We imagine that investors may have little patience or confidence in Nu Skin for a while, understandably. But the bar seems set fairly low now, so we are cautiously optimistic that Nu Skin can dig itself out of this hole as we go through 2016 and Me & Youth roll out more fully.

    Shares of Nu Skin have tumbled 13% to $27.31 at 2:11 p.m. today.

  • [By Roberto Pedone]

    Nu Skin Enterprises (NUS) is a direct selling company, which develops and distributes personal care products and nutritional supplements that are sold under the Nu Skin and Pharmanex brands. This stock closed up 5.4% at $92.96 in Monday’s trading session.

    Monday’s Volume: 2 million

    Three-Month Average Volume: 900,802

    Volume % Change: 85%

    From a technical perspective, NUS ripped higher here right above some near-term support at $85 with heavy upside volume. This move pushed shares of NUS into breakout and new 52-week-high territory, since the stock took out some near-term overhead resistance levels at $88.20 to $89.69. This move also pushed shares of NUS above the upper-end of its recent range that saw the stock trend between $82 to just above $89.

    Traders should now look for long-biased trades in NUS as long as it’s trending above support at $85 and then once it sustains a move or close above Monday’s high of $93.33 with volume that this near or above 900,802 shares. If we get that move soon, then NUS will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $100 to $105.

  • [By Craig Jones]

    Nu Skin Enterprises, Inc. (NYSE: NUS) is trading sharply higher on Friday, but options traders are buying puts in the name, said Jon Najarian. Traders were buying the June 50 puts and they paid around 6 percent for them, so they don't see much upside in Nu Skin Enterprises, explained Najarian. He followed the trade and he is planning to hold the position for a month.

Top 10 Canadian Stocks To Buy For 2018: Talisman Energy Inc.(TLM)

Advisors’ Opinion:

  • [By Jayson Derrick]

    On the other hand, the analysts are Underweight on Eni SpA (ADR) (NYSE: E), Repsol Oil & Gas Canada Inc (USA) (NYSE: TLM) and OMV AG given their asset bases, which offer an inferior risk to reward profile and limited differentiation in cost reductions.

Top 10 Canadian Stocks To Buy For 2018: Patni Computer Systems Limited(PTI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Proteostasis Therapeutics Inc (NASDAQ: PTI) shares shot up 162 percent to $6.16 after the company disclosed 'positive' PTI-428 data with statistical significance.

  • [By William Romov]

    Before we show you our pick, here are the top 10 penny stocks to watch this week

    Penny Stock Current Share Price Nov. 27-Dec. 1 Gain (as of Dec. 1)
    Pyxis Tankers Inc. (Nasdaq: PXS) $4.10 122.83%
    Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.28 68.42%
    Cerecor Inc. (Nasdaq: CERC) $1.74 47.46%
    Proteostasis Therapeutics Inc. (Nasdaq: PTI) $2.52 37.71%
    UT Starcom Holdings Corp. (Nasdaq: UTSI) $5.20 37.20%
    WMIH Corp. (Nasdaq: WMIH) $0.96 33.46%
    PhaseRx Inc. (Nasdaq: PZRX) $0.90 30.29%
    Bellerophon Therapeutics Inc. (Nasdaq: BLPH) $2.04 29.94%
    EV Energy Partners LP (Nasdaq: EVEP) $0.86 27.76%
    Catalyst Pharmaceuticals Inc. (Nasdaq: CPRX) $4.40 25.71%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, its completely free

Top 10 Canadian Stocks To Buy For 2018: NRG Energy Inc.(NRG)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was NRG Energy, Inc. (NYSE: NRG) which rose over 5% to $22.20. The stocks 52-week range is $9.84 to $23.36. Volume was over 35 million compared to its average volume of 5.8 million.

  • [By Ben Levisohn]

    NRG Energy (NRG) has gained 2.1% to $18.49 after getting raise to Buy from Neutral at Goldman Sachs.

    Skechers USA (SKX) has tumbled 5.4% to$28.35 after getting cut to Negative from Positive at Susquehanna.

  • [By Ben Levisohn]

    NRG Energy (NRG) soared to the top of the S&P 500 today.

    Getty Images

    NRG Energygained 4.5% to $12.85 today, while the S&P 500 advanced 0.2% to 2,262.53.

    In a note released on Dec. 15, Morgan Stanley’sStephen Byrd and team summarized the reasoning behind their overweight rating on NRG:

    NRG Energy (NRG, Overweight, $21 PT) FCF/Equity yield of ~35% and balanced upside from diversified market exposure, higher PJM capacity prices, fleet optimization, and debt reduction. NRG’s generation plus retail matching strategy is an underappreciated source of value, and provides stable cash flow despite current depressed power prices in Texas.

    NRG Energy’s market capitalization rose to $4.1 billion today from $3.8 billion yesterday. It reported a net loss of $6.4 billion on sales of $15 billion in 2015.

    NRG Energy was the Biggest Loser on Nov. 10, and the Hot Stock on Nov. 4.

  • [By Lisa Levin]

    Non-cyclical consumer goods & services sector was the top gainer in the US market on Wednesday. Top gainers in the sector included Cia Energetica de Minas Gerais CEMIG-ADR (NYSE: CIG), Companhia Paranaense de Energia (ADR) (NYSE: ELP), and NRG Energy Inc (NYSE: NRG).

  • [By Lisa Levin]

    In trading on Wednesday, utilities shares fell 0.25 percent. Meanwhile, top losers in the sector included NRG Energy Inc (NYSE: NRG), down 3 percent, and Entergy Corporation (NYSE: ETR) down 1 percent.

Top 10 Canadian Stocks To Buy For 2018: Canadian National Railway Company(CNI)

Advisors’ Opinion:

  • [By Monica Gerson]

    Canadian National Railway (USA) (NYSE: CNI) is estimated to post its quarterly earnings at $0.92 per share on revenue of $3.08 billion.

    Container Store Group Inc (NYSE: TCS) is expected to post its quarterly earnings at $0.21 per share on revenue of $230.53 million.

  • [By Brett Hershman]

    The Swiss bank said it was raising first-quarter estimates on four of the six rails it covers, with updated estimates above consensus on Canadian National Railway (USA) (NYSE: CNI), CSX Corporation (NASDAQ: CSX) and Kansas City Southern (NYSE: KSU), which is seen to show upside against low expectations.

  • [By Paul Ausick]

    GE got some good news this past week with an order for 200 locomotives from Canadian National Railway Co. (NYSE: CNI). The locomotives will be built at GE’s plant in Fort Worth, Texas, and deliveries to the rail operator will begin next year. The balance of the locomotives will be delivered in 2019 and 2020.

Top 10 Canadian Stocks To Buy For 2018: Valeant Pharmaceuticals International Inc(VRX)

Advisors’ Opinion:

  • [By Paul Ausick]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped about 3.7% Tuesday to post a new 52-week low of $10.08 after closing Monday at $10.47. The stock’s 52-week high is $38.50. Volume of about 14 million shares was about 30% below the daily average of around 19 million. The company said on Monday that CEO Joseph Papa took home total compensation of nearly $63 million as the stock was losing 62% of its value. The numbers speak for themselves.

  • [By Chris Lange]

    Eyegate Pharmaceuticals Inc. (NASDAQ: EYEG) shares had an incredible gain on Tuesday after the company announced a licensing agreement with Valeant Pharmaceuticals International Inc. (NYSE: VRX). At one point in the day shares were up over 100%. According to the deal, Eyegate has granted a subsidiary of Valeant exclusive, worldwide commercial and manufacturing rights to the Eyegate II Delivery System and EGP-437 combination product candidate for the treatment of post-operative pain and inflammation in ocular surgery patients.

  • [By Peter Graham]

    Controversialmid capspecialty pharmastockValeant Pharmaceuticals International (NYSE: VRX) reportedQ1 2017 earnings before the market opened this morning with shares soaring in premarket trading. Valeant Pharmaceuticalshad beenwidelycriticized for pioneering the highly lucrative business model of acquiring pharmaceutical companies or their drugs, incorporating these drugs intoits sales and supply chain and thenjacking up the prices of these medications to levels contemporaneous with similar pharmaceutical products. In February 2016,the Companydisclosed that it was under investigation by the SEC and by the U.S. Attorney’s Offices for the Southern District of New York and then came under further criticism from politicians.

  • [By Ashley Moore]

    This next company to short continues to make headlines for its purportedly illegal business practices…

    Stocks to Short No. 2: Valeant Pharmaceuticals International Inc. (NYSE: VRX)

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) is known for its questionable business practices. The company is notorious for buying smaller pharmaceutical companies (financed with debt), firing the staff of the newly acquired company, and dramatically raising prices of the new drugs at its disposal.

  • [By Virendra Singh Chauhan]

    Nvidia corporation stock shook off the bad performance from the last week, with a nearly 3% gain in the first trading session of this week. If you are wondering whether or not NVIDIA stock has turned the corner, a recent tweet from NVIDIA bear Andrew Left offers some answers. In late December, Citron’s Andrew Left issued a bearish NVDA call, calling a $90 bottom on the stock. Well, the famed short seller of Valeant (NYSE:VRX) fame, recently disclosed that he had covered its short position on NVIDIA. Given that Citron had originally called for a $90 price target, it appears likely that Citron thinks NVDA stock has bottomed out $10 above its original target.

Top 10 Canadian Stocks To Buy For 2018: Transcananda Pipelines Ltd.(TRP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Energy infrastructure companies ONEOK (NYSE:OKE) and TransCanada (NYSE:TRP) are both emerging from the energy market downturn as stronger entities. Each made smart acquisitions, with TransCanada buying U.S. gas pipeline company Columbia Pipeline Group, while ONEOK is in the process of gobbling up its MLP,ONEOK Partners (NYSE:OKS). While these deals enhanced the growth profiles of both companies, TransCanada still stands out as the better buy for long-term income investors. Here’s why.

  • [By WWW.KIPLINGER.COM]

    Energy stocks were driven by a hefty dose of M&A during the third quarter. And that will drive returns for TransCanada Corporation (TRP) during the next one.

  • [By Matthew DiLallo]

    After a series of setbacks in its attempts to build new oil pipelines, Canadian pipeline giant TransCanada (NYSE:TRP) completed a transformation transaction to acquire U.S. natural gas pipeline company Columbia Pipeline Group for $13 billion, which includes the assumption of debt. The key to that deal was that it increased the combined company’s near-term project pipeline to 23 billion Canadian dollars, which supports TransCanada’s ability to increase its dividend by 8% to 10% annually through 2020. After completing that deal, TransCanada made a bid to acquire all of the outstanding units that it did not own of affiliated MLP Columbia Pipeline Partners (NYSE:CPPL) in a transaction valued at $915 million. These acquisitions solidified TransCanada’s natural gas pipeline growth ambitions, enabling it to diversify away from oil pipelines.

  • [By Ben Levisohn]

    In a number of articles recently, following the US recent revival and potential approval of the previously blocked Keystone XL pipeline, a number of estimates have been provided suggesting a pending boom for the US steel industry is on the horizon (and US steel stocks have reacted in kind). In fact, this optimism, we believe, peaked today when a report from one of our competitors was published claiming that, the keystone XL pipeline could increase line pipe demand by 14.7% for 2 years. The problem here, we believe, rests with the facts that: (a) TransCanada (TRP) has already taken, and paid for, the steel to build the Keystone XL pipeline (the steel currently sits in storage facilities in both Regina, Canada and Arkansas, United States), (b) neither US Steel (X; SELL), AK Steel, Steel Dynamics, or Nucor have the ability to make the specialized steel required for the miles of pipe associated with this project, to include both the thickness and pressure requirements, according to this article from Reuters, and (c) assuming some of the pipe does need replacement, this would likely come from international steel makers who are capable of producing the specialized steel (again, as highlighted in this Reuters article).

  • [By Paul Ausick]

    That includes pipeline companies like Kinder Morgan Inc. (NYSE: KMI), which already operates a pipeline transporting natural gas from Texas into Mexico, and master limited partnerships (MLPs) Energy Transfer Partners L.P. (NYSE: ETP) and TransCanada Corp. (NYSE: TRP), the company that has (so far) failed to get U.S. approval for its Keystone Pipeline expansion from Canada’s oil sands across the U.S. border.

Top 10 Canadian Stocks To Buy For 2018: Credit Suisse Group(CS)

Advisors’ Opinion:

  • [By Paul R. La Monica]

    European banks worse off than 2008? Lamensdorf is concerned about the exposure to bad loans (especially energy company debt) held by big banks such as Royal Bank of Scotland (RBS), Credit Suisse (CS) and Deutsche Bank (DB). He’s shorting all three.

  • [By David Zeiler]

    The federal government’s largesse isn’t restricted to U.S.-based companies, either. Foreign companies, including foreign banks, are also welcome. Credit Suisse Group AG (NYSE ADR: CS) got $225.1 billion, and UBS Group AG (NYSE: UBS) got $249.1 billion.

  • [By Money Morning News Team]

    That’s why Krauth predicts the price of gold will hit $1,400 by the end of the year. Many analysts from banks likeCredit SuisseGroup AG (NYSE ADR: CS) even see gold going as high as $1,500.

  • [By Wayne Duggan] Related DB Deutsche Bank In The Tank Mike Khouw Sees Unusual Options Activity In Deutsche Bank 33 Large Banks On The Federal Reserve's Radar In 2016 (Seeking Alpha)
    Related CS Earnings Scheduled For February 4, 2016 Blockchain Moves Forward In The Financial Industry Credit Suisse Group AG (CS) Tidjane Thiam on Q4 2015 Results – Earnings Call Transcript (Seeking Alpha)

    The latest credit default swap (CDS) data from BMO Capital Markets indicate a number of investors are growing increasingly concerned about the one-year outlook for capital markets. In a new report, analyst Mark Steele discussed the recent surge in one-year CDS activity, and what it means for the market.

  • [By Diane Alter]

    The head underwriters for the ZTO IPO are Morgan Stanley (NYSE: MS) and Goldman Sachs Group Inc. (NYSE: GS). Also working on the deal are China Renaissance, Citigroup Inc. (NYSE: C), Credit Suisse Group AG (NYSE ADR: CS), and JPMorgan Chase & Co. (NYSE: JPM).

Top 10 Canadian Stocks To Buy For 2018: Prestige Brand Holdings Inc.(PBH)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Castor believes the cash has disappeared into working capital, which has grown from 23% to more than 50% since 2008. Comparable company PrestigeBrand (PBH) uses 11%; Unilever(UL) and Colgate-Palmolive(CL) far less.

Top 10 Canadian Stocks To Buy For 2018: Safeway Inc.(SWY)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of small cap SUPERVALU now underperforming large cap Kroger Co (NYSE: KR) while shares of large cap Whole Foods Market, Inc (NASDAQ: WFM) and mid cap Safeway Inc (NYSE: SWY) appear to be back to where they started at:

  • [By Peter Graham]

    A long term performance chart shows shares of SUPERVALU underperforming the underperformance ofmid caps Whole Foods Market, Inc (NASDAQ: WFM) and Safeway Inc (NYSE: SWY). while large capKroger Co (NYSE: KR)had outperformed up until the last two years when performance has been more mixed:

Hot Canadian Stocks To Watch Right Now

In recent weeks we’ve been talking about the impact of blockchain technology on industries outside the financial sector and how this technology is enhancing security for both consumers and vendors. In keeping with this trend, and consistent with its focus on providing cutting edge technology to the hospitality industry, Toronto, Ontario based Posera Ltd. (TSX: PAY.TO, OTCQB: PRRSF) announced on Friday a collaboration with Shift4 Corporation. Shift4’s DOLLARS ON THE NET integrates with Posera’s Maitre’D to support credit, debit, and gift card transactions, and provides out-of-the-box support for U.S. and Canadian EMV (Europay, MasterCard, Visa), point-to-point encryption and tokenization. Their offering includes comprehensive auditing and accounting tools, the industry’s best uptime and simple adoption of emerging and alternative payment methods, such as mobile wallets.

Hot Canadian Stocks To Watch Right Now: Natural Gas(NG)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    Canadian gold mining company NovaGold Resources Inc. (NYSE: NG) shows an even starker change in sentiment. In the last 12 months, the volume of short bets on the stock declined 79%, to 522,400.

  • [By William Romov]

    Over the last year, the number of short positions on gold stocks has fallen. One of these stocks is a Canadian gold mining company called NovaGold Resources Inc. (NYSE: NG). In the last 12 months, the volume of short bets on the stock declined 79%, to 522,400. This shows a shift in sentiment from bearish to bullish for gold.

  • [By James E. Brumley]

    When an investor thinks of Canadian gold mining stocks, NovaGold Resources Inc. (USA) (NYSEMKT:NG) and Yamana Gold Inc. (USA) (NYSE:AUY) are often the first names to come to mind. And well they should. Yamana Gold is a $2.5 billion giant, and NovaGold Resources seems to have been around forever.

    Those two icons aren’t the only way to tap into Canada’s sizeable gold mining industry though. There’s a small, up-and-coming player called Taranis Resources Inc. (OTCMKTS:TNREF, TSX:TRO) that could end up becoming another key fixture of the country’s mining landscape.

    Taranis develops mineral deposits into mine-ready projects. Its primary project right now — and it’s enough to keep the company plenty busy for the next several years — is the Thor property located near Trout Lake, British Columbia. NI 43-101 resource reports (indicated and inferred)suggest Thor contains 6.9 million ounces of silver, 35,000 ounces gold, 57 million pounds of lead, 79.4 million pounds of zinc and 3.3 Million pounds of copper (roughly a 14 million ounce silver equivalent (“AgEq”) deposit*) laying in wait in a way that lends itself to the establishment of a low-cost, open pit mining operation. That’s roughly $300 million worth of marketable metals, and the estimates have been steadily getting bigger as Tanaris does more survey work.

    And 2017 could be a real breakout year for Taranis, as a lot of the work that’s been done to date starts to mean something. It’s got big exploration plans for this year… this spring/summer to be exact.

    The Phase 1 program was completed in September of last year, setting the stage for a more defined and much bigger Phase 2 definition-drilling within the next several weeks. This Phase 2 definition drilling slated for the middle of this year will drill down to between 6000 m and 10,000 m.

    These so-called first generation target areas are generally well understood areas based on sound geological information includ

Hot Canadian Stocks To Watch Right Now: Encana Corporation(ECA)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Vodafone Group (VOD) , Schlumberger (SLB) , Encana (ECA) , Arconic (ARNC) and AdvanSix (ASIX) .

    Cramer was bearish on U.S. Silica Holdings (SLCA) .

  • [By Paul Ausick]

    Encana Corp. (NYSE: ECA) is rated Buy with an unchanged price target of $16. The EPS estimate for 2017 was lowered from $0.42 to $0.34, and the 2018 estimate was also lowered, from $1.47 to $1.28. The shares ended the weekat $11.44, in a 52-week range of $4.90 to $13.85. The consensus 12-month price target is $14.95.

  • [By Money Morning News Team]

    Canada-based Encana Corp. (NYSE: ECA) was the eighth top oil company stock in 2016, with a 131% gain over the year. ECA and its subsidiaries focus on developing, exploring, producing, and marketing natural gas, liquefied natural gas, and oil in North America.

Hot Canadian Stocks To Watch Right Now: ConocoPhillips(COP)

Advisors’ Opinion:

  • [By Matthew DiLallo, Tyler Crowe, and Jason Hall]

    Oil prices haven’t gotten off to the fast start many expected, falling around 6% on average during the first quarter of the year. That slump came despite OPEC’s best efforts since producing nations have achieved fairly good compliance on their planned output cuts. That said, despite the lackluster oil market, we still see some interestingopportunities in the oil market. Three stocks we really like right now are DistributionNOW(NYSE:DNOW),Phillips 66(NYSE:PSX), andConocoPhillips(NYSE:COP), which all should do well in the current oil market.

  • [By Matthew DiLallo]

    Oil exploration is a risky business. Not only does it cost a lot of money, but the odds of drilling a dry hole are very high. Just ask ConocoPhillips (NYSE:COP), which recorded $432 million of deepwater dry hole costs last year. It’s a problem the company is working to address by stepping away from deepwater exploration so that it can deliver steadier returns for investors.

  • [By Matthew DiLallo]

    Meanwhile, ConocoPhillips (NYSE:COP) also abandoned its leases in the Chukchi Sea earlier this year. It paid $506 million for the 98 leases off Alaska’s northern coast in 2008 and had plans to drill its first exploratory well in 2014 but dropped those ambitions due to regulatory uncertainty. It has also since decided to exit deepwater exploration altogether after drilling a string of dry holes in the Gulf of Mexico, offshore Angola, and the Canadian Atlantic, Instead, ConocoPhillips plans to focus its future development efforts on lower-risk onshore shale development.

Hot Canadian Stocks To Watch Right Now: Nu Skin Enterprises Inc.(NUS)

Advisors’ Opinion:

  • [By Craig Jones]

    Nu Skin Enterprises, Inc. (NYSE: NUS) is trading sharply higher on Friday, but options traders are buying puts in the name, said Jon Najarian. Traders were buying the June 50 puts and they paid around 6 percent for them, so they don't see much upside in Nu Skin Enterprises, explained Najarian. He followed the trade and he is planning to hold the position for a month.

  • [By Roberto Pedone]

    Nu Skin Enterprises (NUS) is a direct selling company, which develops and distributes personal care products and nutritional supplements that are sold under the Nu Skin and Pharmanex brands. This stock closed up 5.4% at $92.96 in Monday’s trading session.

    Monday’s Volume: 2 million

    Three-Month Average Volume: 900,802

    Volume % Change: 85%

    From a technical perspective, NUS ripped higher here right above some near-term support at $85 with heavy upside volume. This move pushed shares of NUS into breakout and new 52-week-high territory, since the stock took out some near-term overhead resistance levels at $88.20 to $89.69. This move also pushed shares of NUS above the upper-end of its recent range that saw the stock trend between $82 to just above $89.

    Traders should now look for long-biased trades in NUS as long as it’s trending above support at $85 and then once it sustains a move or close above Monday’s high of $93.33 with volume that this near or above 900,802 shares. If we get that move soon, then NUS will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $100 to $105.

  • [By Ben Levisohn]

    Citigroup’s Beth Kite calls Nu Skin Enterprises’ (NUS) earnings and guidance “awfully disappointing.” She explains why:

    “Frustrating” Describes 4Q15 & 2016 Guidance:Nu Skin (i) reported 4Q15 EPS of $0.62, 11 cents below consensus and us, and (ii) lowered 2016 EPS guidance, from $3.25-$3.40 to $2.40-$2.60.Nu Skin had three LTO’s in 4Q152 succeeded and 1 failed. The failure had far less to do with the product than with the sales strategy…

    Is Guidance Too Conservative or Is It Really This Bad? We get that Me failed to sell well in South Korea with the 12-month cartridge commitment. But given the strength in reps globally, the strength of Youth from its two LTOs in 2H15, and good results from Me when sold in Japan without the 12-month commitment, we wonder if guidance is aggressive to the downside. Indeed, the word “conservative” was said a lot by mgmt on the brief earnings call when describing guidance revisions.

    Maintaining Buy: While we now have less confidence in mgmt, from an external perspective, to forecast its results accurately, and from an internal perspective, to course correct quicklyi.e., why didn’t they drop the 12-month plan for Me in South Korea when it so obviously wasn’t workingwe are still confident in Youth & Me. The rep growth in South Asia/Pacific from Youth in 3Q led to better 4Q sales than we’d expected, Youth’s Americas LTO in 4Q drove lc sales up 26% YoY, and Me not only sold through in Japan in 4Q but also drove reps higher. We imagine that investors may have little patience or confidence in Nu Skin for a while, understandably. But the bar seems set fairly low now, so we are cautiously optimistic that Nu Skin can dig itself out of this hole as we go through 2016 and Me & Youth roll out more fully.

    Shares of Nu Skin have tumbled 13% to $27.31 at 2:11 p.m. today.

  • [By Scott Rubin]

    Stock gainers included Mercadolibre Inc (NASDAQ: MELI), up almost 14 percent, and Nu Skin Enterprises, Inc. (NYSE: NUS), which added 12 percent. The positive gains in both stocks were due to strong earnings reports. Shares of Liberty Interactive Group (NASDAQ: QVCA) plunged almost 22 percent on Friday due to disappointing sales growth in its fiscal second quarter. Pharmaceutical giant Bristol-Myers Squibb Co (NYSE: BMY) lost 16 percent after a disappointing study involving its Opdivo drug.

Hot Canadian Stocks To Watch Right Now: Credit Suisse Group(CS)

Advisors’ Opinion:

  • [By Paul R. La Monica]

    European banks worse off than 2008? Lamensdorf is concerned about the exposure to bad loans (especially energy company debt) held by big banks such as Royal Bank of Scotland (RBS), Credit Suisse (CS) and Deutsche Bank (DB). He’s shorting all three.

  • [By Diane Alter]

    The head underwriters for the ZTO IPO are Morgan Stanley (NYSE: MS) and Goldman Sachs Group Inc. (NYSE: GS). Also working on the deal are China Renaissance, Citigroup Inc. (NYSE: C), Credit Suisse Group AG (NYSE ADR: CS), and JPMorgan Chase & Co. (NYSE: JPM).

  • [By David Zeiler]

    The federal government’s largesse isn’t restricted to U.S.-based companies, either. Foreign companies, including foreign banks, are also welcome. Credit Suisse Group AG (NYSE ADR: CS) got $225.1 billion, and UBS Group AG (NYSE: UBS) got $249.1 billion.

  • [By Money Morning News Team]

    That’s why Krauth predicts the price of gold will hit $1,400 by the end of the year. Many analysts from banks likeCredit SuisseGroup AG (NYSE ADR: CS) even see gold going as high as $1,500.

  • [By Wayne Duggan] Related DB Deutsche Bank In The Tank Mike Khouw Sees Unusual Options Activity In Deutsche Bank 33 Large Banks On The Federal Reserve's Radar In 2016 (Seeking Alpha)
    Related CS Earnings Scheduled For February 4, 2016 Blockchain Moves Forward In The Financial Industry Credit Suisse Group AG (CS) Tidjane Thiam on Q4 2015 Results – Earnings Call Transcript (Seeking Alpha)

    The latest credit default swap (CDS) data from BMO Capital Markets indicate a number of investors are growing increasingly concerned about the one-year outlook for capital markets. In a new report, analyst Mark Steele discussed the recent surge in one-year CDS activity, and what it means for the market.

Hot Canadian Stocks To Watch Right Now: Silver Wheaton Corp(SLW)

Advisors’ Opinion:

  • [By Rich Duprey]

    Silver Wheaton (NYSE:SLW), of course, is a streamer like Sandstorm and Franco, but it is the largest in the precious-metals industry, and arguably the best-known, because its business model came to define what streaming is. Although it is known primarily for its silver contracts, Silver Wheaton also has sizable gold production that makes it worth your attention.

Hot Canadian Stocks To Buy Right Now

&l;p&g;&l;img class=&q;dam-image bloomberg size-large wp-image-41695972&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/41695972/960×0.jpg?fit=scale&q; data-height=&q;639&q; data-width=&q;960&q;&g; Jeff Sessions, U.S. attorney general, pauses after speaking during a House Judiciary Committee hearing in Washington, D.C., U.S., on Tuesday, Nov. 14, 2017. Andrew Harrer/Bloomberg

Marijuana stocks and exchange-traded funds were on fire in the New Year until Attorney General Jeff Sessions ignited a selloff Thursday upon announcing that he&a;rsquo;s retracting the Cole Memo, which lets individual states legalize cannabis without fear federal prosecutors will go after companies for trafficking.

Cannabics Pharmaceuticals, Medical Marijuana, United Cannabis, GreenGro Technologies, MassRoots and mCig crashed 25% to 30% each after flying high the two sessions prior as California&a;rsquo;s new marijuana laws went into effect. ETFMG Alternative Harvest ETF plunged 6%. Its Canadian counterpart, Horizons Marijuana Life Sciences Index ETF, dropped 8%. It trades over the counter in the U.S. under the ticker HMLSF.

Hot Canadian Stocks To Buy Right Now: Safeway Inc.(SWY)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of SUPERVALU underperforming the underperformance ofmid caps Whole Foods Market, Inc (NASDAQ: WFM) and Safeway Inc (NYSE: SWY). while large capKroger Co (NYSE: KR)had outperformed up until the last two years when performance has been more mixed:

  • [By Peter Graham]

    A long term performance chart shows shares of small cap SUPERVALU now underperforming large cap Kroger Co (NYSE: KR) while shares of large cap Whole Foods Market, Inc (NASDAQ: WFM) and mid cap Safeway Inc (NYSE: SWY) appear to be back to where they started at:

Hot Canadian Stocks To Buy Right Now: NRG Energy Inc.(NRG)

Advisors’ Opinion:

  • [By Rich Duprey]

    I ran a screen to identify the best-performing stocks from the S&P 500 in January. The top three performers during the month were Alcoa (NYSE:AA), CSX (NASDAQ:CSX), and NRG Energy (NYSE:NRG). Let’s see why they were the big standouts and whether they can keep it going.

  • [By Ben Levisohn]

    NRG Energy (NRG) soared to the top of the S&P 500 today.

    Getty Images

    NRG Energygained 4.5% to $12.85 today, while the S&P 500 advanced 0.2% to 2,262.53.

    In a note released on Dec. 15, Morgan Stanley’sStephen Byrd and team summarized the reasoning behind their overweight rating on NRG:

    NRG Energy (NRG, Overweight, $21 PT) FCF/Equity yield of ~35% and balanced upside from diversified market exposure, higher PJM capacity prices, fleet optimization, and debt reduction. NRG’s generation plus retail matching strategy is an underappreciated source of value, and provides stable cash flow despite current depressed power prices in Texas.

    NRG Energy’s market capitalization rose to $4.1 billion today from $3.8 billion yesterday. It reported a net loss of $6.4 billion on sales of $15 billion in 2015.

    NRG Energy was the Biggest Loser on Nov. 10, and the Hot Stock on Nov. 4.

  • [By Lisa Levin]

    In trading on Wednesday, utilities shares fell 0.25 percent. Meanwhile, top losers in the sector included NRG Energy Inc (NYSE: NRG), down 3 percent, and Entergy Corporation (NYSE: ETR) down 1 percent.

  • [By Craig Jones]

    Pete Najarian said that there was a big options activity in NRG Energy Inc (NYSE: NRG). Traders were aggressively buying the October 26 calls. Around 6,000 contracts were traded in the first half of the session and they were paying 65 cents for them. The trade breaks even at $26.65 or more than 11 percent above the current market price.

Hot Canadian Stocks To Buy Right Now: Valeant Pharmaceuticals International Inc(VRX)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Apache Corp. (NYSE: APA), Halliburton Co. (NYSE: HAL), Revlon Inc. (NYSE: REV), Valeant Pharmaceuticals International Inc. (NYSE: VRX) and U.S. Steel Corp. (NYSE: X).

  • [By Keith Speights]

    It’s been a long time since Valeant Pharmaceuticals (NYSE:VRX) stock was in a legitimate uptrend. Despite the hiring of a new CEO last year to right the ship, Valeant’s share price has continued to fall.

  • [By Ben Levisohn]

    The gain is particularly striking considering the fact that Endo International dropped 73% in 2016, making it the worst performer in the S&P 500. Endo has been hit hard by concerns over drug pricing that has plagued the entire specialty pharmaceutical sector since Valeant Pharmaceuticals International’s (VRX) pricing strategy came to light last year.

  • [By Casey Wilson]

    As disgraceful as Mylan’s pricing strategy may be, this next pharmaceutical firm is hated even more – and makes our list for the second year in a row…

    Most-Hated Companies 2016 No. 1: Valeant Pharmaceuticals International Inc. (NYSE: VRX)

    The troubled pharmaceutical company is deeply loathed by both consumers and investors alike.

  • [By Kumar Abhishek]

    Shares of specialty pharma company Valeant Pharmaceuticals Intl Inc(NYSE:VRX)have tanked more than 20% in last two trading sessions, breaching the support from the 50 day SMA, after the Laval,Quebec-based company reported its Q4 and FY 2016 earnings on Tuesday, before the market opened. While the earnings itself were better than expected, the guidance for FY 2017 didn’t go down well with investors and wall street, earning the company multiple price target cuts. Valeant reported an adjusted profit of $1.26 a share against analysts’ estimateof $1.21. This was Valeant’s first beat in a long time. Even on the revenue front, the company reported better than expected results. Initially, the stock gained on the report of an earnings beat. However, once the guidance figures came in, the stock tanked. In our earnings preview of Valeant, we had said that the adjusted EBITDA guidance for 2017 will be the key driver of VRX stock after the earnings.

  • [By Paul Ausick]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped about 0.1% Thursday to post a new 52-week low of $9.49 after closing Wednesday at $9.50. The stock’s 52-week high is $38.50. Volume of about 15 million shares was about 25% below the daily average of around 19 million. The company had no specific news.

Hot Canadian Stocks To Buy Right Now: Patni Computer Systems Limited(PTI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Proteostasis Therapeutics Inc (NASDAQ: PTI) shares shot up 162 percent to $6.16 after the company disclosed 'positive' PTI-428 data with statistical significance.

  • [By William Romov]

    Before we show you our pick, here are the top 10 penny stocks to watch this week

    Penny Stock Current Share Price Nov. 27-Dec. 1 Gain (as of Dec. 1)
    Pyxis Tankers Inc. (Nasdaq: PXS) $4.10 122.83%
    Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.28 68.42%
    Cerecor Inc. (Nasdaq: CERC) $1.74 47.46%
    Proteostasis Therapeutics Inc. (Nasdaq: PTI) $2.52 37.71%
    UT Starcom Holdings Corp. (Nasdaq: UTSI) $5.20 37.20%
    WMIH Corp. (Nasdaq: WMIH) $0.96 33.46%
    PhaseRx Inc. (Nasdaq: PZRX) $0.90 30.29%
    Bellerophon Therapeutics Inc. (Nasdaq: BLPH) $2.04 29.94%
    EV Energy Partners LP (Nasdaq: EVEP) $0.86 27.76%
    Catalyst Pharmaceuticals Inc. (Nasdaq: CPRX) $4.40 25.71%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, its completely free

Hot Canadian Stocks To Buy Right Now: Plains All American Pipeline L.P.(PAA)

Advisors’ Opinion:

  • [By Dustin Parrett]

    We think Plains All American Pipeline L.P. (NYSE: PAA) is one of the best oil stocks to buy this year. In fact, we see a scenario where PAA stock could jump 20% in 2017.

  • [By Dustin Parrett]

    Plains All American Pipeline (NYSE: PAA) controls 4 million barrels of crude oil and natural gas a day.

    And with higher oil prices and fewer restrictions leading to more drilling, PAA’s pipelines will be in demand in 2017.

  • [By Matthew DiLallo]

    One of the largest projects is the Saddlehorn Pipeline, which Magellan is building with Plains All American Pipeline (NYSE:PAA) and Anadarko Petroleum (NYSE:APC). Both Plains All American Pipeline and Magellan own 40% of the project, which puts their total investment at $230 million apiece. They expect the project to be fully operational early next year, which is noteworthy given its robust first-year economics. Magellan estimates that it will earn eight times EBITDA on the capital deployed, or roughly $28.8 million in annual EBITDA apiece for Magellan and Plains All American Pipeline on their investment.

Hot Canadian Stocks To Buy Right Now: Nu Skin Enterprises Inc.(NUS)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Nu Skin Enterprises (NUS) is a direct selling company, which develops and distributes personal care products and nutritional supplements that are sold under the Nu Skin and Pharmanex brands. This stock closed up 5.4% at $92.96 in Monday’s trading session.

    Monday’s Volume: 2 million

    Three-Month Average Volume: 900,802

    Volume % Change: 85%

    From a technical perspective, NUS ripped higher here right above some near-term support at $85 with heavy upside volume. This move pushed shares of NUS into breakout and new 52-week-high territory, since the stock took out some near-term overhead resistance levels at $88.20 to $89.69. This move also pushed shares of NUS above the upper-end of its recent range that saw the stock trend between $82 to just above $89.

    Traders should now look for long-biased trades in NUS as long as it’s trending above support at $85 and then once it sustains a move or close above Monday’s high of $93.33 with volume that this near or above 900,802 shares. If we get that move soon, then NUS will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $100 to $105.

  • [By Ben Levisohn]

    Citigroup’s Beth Kite calls Nu Skin Enterprises’ (NUS) earnings and guidance “awfully disappointing.” She explains why:

    “Frustrating” Describes 4Q15 & 2016 Guidance:Nu Skin (i) reported 4Q15 EPS of $0.62, 11 cents below consensus and us, and (ii) lowered 2016 EPS guidance, from $3.25-$3.40 to $2.40-$2.60.Nu Skin had three LTO’s in 4Q152 succeeded and 1 failed. The failure had far less to do with the product than with the sales strategy…

    Is Guidance Too Conservative or Is It Really This Bad? We get that Me failed to sell well in South Korea with the 12-month cartridge commitment. But given the strength in reps globally, the strength of Youth from its two LTOs in 2H15, and good results from Me when sold in Japan without the 12-month commitment, we wonder if guidance is aggressive to the downside. Indeed, the word “conservative” was said a lot by mgmt on the brief earnings call when describing guidance revisions.

    Maintaining Buy: While we now have less confidence in mgmt, from an external perspective, to forecast its results accurately, and from an internal perspective, to course correct quicklyi.e., why didn’t they drop the 12-month plan for Me in South Korea when it so obviously wasn’t workingwe are still confident in Youth & Me. The rep growth in South Asia/Pacific from Youth in 3Q led to better 4Q sales than we’d expected, Youth’s Americas LTO in 4Q drove lc sales up 26% YoY, and Me not only sold through in Japan in 4Q but also drove reps higher. We imagine that investors may have little patience or confidence in Nu Skin for a while, understandably. But the bar seems set fairly low now, so we are cautiously optimistic that Nu Skin can dig itself out of this hole as we go through 2016 and Me & Youth roll out more fully.

    Shares of Nu Skin have tumbled 13% to $27.31 at 2:11 p.m. today.

  • [By Craig Jones]

    Nu Skin Enterprises, Inc. (NYSE: NUS) is trading sharply higher on Friday, but options traders are buying puts in the name, said Jon Najarian. Traders were buying the June 50 puts and they paid around 6 percent for them, so they don't see much upside in Nu Skin Enterprises, explained Najarian. He followed the trade and he is planning to hold the position for a month.

Hot Undervalued Stocks To Own For 2018

After beating the Q4 earnings, Micron’s (MU) stock price surged. Now is the perfect time to ask, is it still a good time to buy?

I believe so. Micron has solid plans to increase its earnings for next year, groundbreaking proprietary technology with unknown potential, a P/E way below the industry average and reasonable debt. It is a healthy company, heavily undervalued and with little risk.

Valuation

Whether compared to its peers or its earnings growth, Micron has a very low P/E ratio. Although sometimes a low P/E ratio is a sign of a company in distress, this is not the case. The long-term debt to revenue ratio seems acceptable, and even low when compared to its peers. From Q3 to Q4, long-term debt was reduced and this trend is expected to continue.

Hot Undervalued Stocks To Own For 2018: Barclays PLC(BCS)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Barclays PLC (NYSE: BCS) was raised to Overweight from Equal Weight at Morgan Stanley. Its American depositary sharesclosed up 2.6% at $11.36 on Thursday and were indicated up 1.2% at $11.50 on Friday. The52-week range is $6.76 to $12.05.

  • [By WWW.THESTREET.COM]

    Banco Santander (SAN) : “I prefer Barclays (BCS) , but let’s wait and see what the other banks have to say”

    ProLogis (PLD) : “I am not a fan of that group right now, but that one is best of breed.”

Hot Undervalued Stocks To Own For 2018: Internet Initiative Japan Inc.(IIJI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, telecommunications services shares fell by 0.29 percent. Meanwhile, top losers in the sector included Telecom Italia SpA (ADR) (NYSE: TI), down 4 percent, and Internet Initiative Japan Inc. (ADR) (NASDAQ: IIJI), down 3 percent.

  • [By Lisa Levin]

    In trading on Wednesday, telecommunications services shares rose by just 0.03 percent. Meanwhile, top losers in the sector included Internet Initiative Japan Inc. (ADR) (NASDAQ: IIJI), down 4 percent, and DigitalGlobe Inc (NYSE: DGI), down 2 percent.

  • [By Lisa Levin]

    In trading on Thursday, telecommunications services shares fell 0.29 percent. Meanwhile, top losers in the sector included China Unicom (Hong Kong) Limited (ADR) (NYSE: CHU), down 6 percent, and Internet Initiative Japan Inc. (ADR) (NASDAQ: IIJI), down 2 percent.

Hot Undervalued Stocks To Own For 2018: AVG Technologies N.V.(AVG)

Advisors’ Opinion:

  • [By Igor Novgorodtsev]

    InterActiveCorp (IACI) bought Ask.com for $1.85 billion in 2005. The new Perion will be worth only about 40% of that. After the merger, Perion will leapfrog its much larger rivals: Babylon and AVG (AVG). Finally, Perion should be able to increase its operating margins as it can spread its SG&A costs over a much larger base (Conduit EBITDA margin is 32% vs. Perion’s 23%). Perion will keep its senior management team intact: Josef Mandelbaum will remain its CEO and Yacov Kaufman its CFO. Perion has successfully orchestrated a roll-up acquisitions of privately-held Sweetpacks and Smilebox, so I have high confidence that they know how to integrate a new business.

Hot Undervalued Stocks To Own For 2018: Franklin Covey Company(FC)

Advisors’ Opinion:

  • [By Monica Gerson]

     

    Darden Restaurants, Inc. (NYSE: DRI) is estimated to report its quarterly earnings at $1.08 per share on revenue of $1.81 billion.
    ConAgra Foods Inc (NYSE: CAG) is expected to report its quarterly earnings at $0.52 per share on revenue of $2.89 billion.
    Paychex, Inc. (NASDAQ: PAYX) is projected to report its quarterly earnings at $0.49 per share on revenue of $751.52 million.
    Micron Technology, Inc. (NASDAQ: MU) is expected to post a quarterly loss at $0.09 per share on revenue of $2.95 billion.
    McCormick & Company, Incorporated (NYSE: MKC) is estimated to report its quarterly earnings at $0.74 per share on revenue of $1.06 billion.
    Constellation Brands, Inc. (NYSE: STZ) is expected to report its quarterly earnings at $1.51 per share.
    Schnitzer Steel Industries, Inc. (NASDAQ: SCHN) is estimated to report its quarterly earnings at $0.18 per share on revenue of $356.41 million.
    Franklin Covey Co. (NYSE: FC) is expected to post its quarterly earnings at $0.08 per share on revenue of $49.89 million.
    Lindsay Corporation (NYSE: LNN) is projected to report its quarterly earnings at $0.99 per share on revenue of $148.43 million.

    Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

Hot Undervalued Stocks To Own For 2018: Nu Skin Enterprises Inc.(NUS)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Citigroup’s Beth Kite calls Nu Skin Enterprises’ (NUS) earnings and guidance “awfully disappointing.” She explains why:

    “Frustrating” Describes 4Q15 & 2016 Guidance:Nu Skin (i) reported 4Q15 EPS of $0.62, 11 cents below consensus and us, and (ii) lowered 2016 EPS guidance, from $3.25-$3.40 to $2.40-$2.60.Nu Skin had three LTO’s in 4Q152 succeeded and 1 failed. The failure had far less to do with the product than with the sales strategy…

    Is Guidance Too Conservative or Is It Really This Bad? We get that Me failed to sell well in South Korea with the 12-month cartridge commitment. But given the strength in reps globally, the strength of Youth from its two LTOs in 2H15, and good results from Me when sold in Japan without the 12-month commitment, we wonder if guidance is aggressive to the downside. Indeed, the word “conservative” was said a lot by mgmt on the brief earnings call when describing guidance revisions.

    Maintaining Buy: While we now have less confidence in mgmt, from an external perspective, to forecast its results accurately, and from an internal perspective, to course correct quicklyi.e., why didn’t they drop the 12-month plan for Me in South Korea when it so obviously wasn’t workingwe are still confident in Youth & Me. The rep growth in South Asia/Pacific from Youth in 3Q led to better 4Q sales than we’d expected, Youth’s Americas LTO in 4Q drove lc sales up 26% YoY, and Me not only sold through in Japan in 4Q but also drove reps higher. We imagine that investors may have little patience or confidence in Nu Skin for a while, understandably. But the bar seems set fairly low now, so we are cautiously optimistic that Nu Skin can dig itself out of this hole as we go through 2016 and Me & Youth roll out more fully.

    Shares of Nu Skin have tumbled 13% to $27.31 at 2:11 p.m. today.

  • [By Scott Rubin]

    Stock gainers included Mercadolibre Inc (NASDAQ: MELI), up almost 14 percent, and Nu Skin Enterprises, Inc. (NYSE: NUS), which added 12 percent. The positive gains in both stocks were due to strong earnings reports. Shares of Liberty Interactive Group (NASDAQ: QVCA) plunged almost 22 percent on Friday due to disappointing sales growth in its fiscal second quarter. Pharmaceutical giant Bristol-Myers Squibb Co (NYSE: BMY) lost 16 percent after a disappointing study involving its Opdivo drug.

  • [By Roberto Pedone]

    Nu Skin Enterprises (NUS) is a direct selling company, which develops and distributes personal care products and nutritional supplements that are sold under the Nu Skin and Pharmanex brands. This stock closed up 5.4% at $92.96 in Monday’s trading session.

    Monday’s Volume: 2 million

    Three-Month Average Volume: 900,802

    Volume % Change: 85%

    From a technical perspective, NUS ripped higher here right above some near-term support at $85 with heavy upside volume. This move pushed shares of NUS into breakout and new 52-week-high territory, since the stock took out some near-term overhead resistance levels at $88.20 to $89.69. This move also pushed shares of NUS above the upper-end of its recent range that saw the stock trend between $82 to just above $89.

    Traders should now look for long-biased trades in NUS as long as it’s trending above support at $85 and then once it sustains a move or close above Monday’s high of $93.33 with volume that this near or above 900,802 shares. If we get that move soon, then NUS will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $100 to $105.

  • [By Craig Jones]

    Nu Skin Enterprises, Inc. (NYSE: NUS) is trading sharply higher on Friday, but options traders are buying puts in the name, said Jon Najarian. Traders were buying the June 50 puts and they paid around 6 percent for them, so they don't see much upside in Nu Skin Enterprises, explained Najarian. He followed the trade and he is planning to hold the position for a month.

top stocks invest now

When they imagine how their divorce negotiations will go, couples tend to think about the largest marital assets first. They usually discuss who’ll get the houses, cars, furniture, and other tangible items. Then, they deliberate over how cash balances can be split. Spousal and/or child support may take time to hash out, but it is never overlooked; on the contrary, pursuing or avoiding it may consume most of the time at the negotiating table.

However, some aspects of the division of marital assets can fall through the cracks, particularly when a woman doesn’t have a qualified divorce financial advisor on her team to guide the process. In some cases, certain marital assets are overlooked because they, or the steps required to divide them, are significantly complicated. In other cases, it’s because of potential future circumstances that nobody thinks to plan for. Either way, divorcing women—many of whom are still, unfortunately, less savvy about finances than their husbands—frequently find themselves at a disadvantage.

top stocks invest now: Endologix, Inc.(ELGX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Endologix, Inc. (NASDAQ: ELGX) shares dropped 23 percent to $7.59 as the company issued an update on Nellix PMA process. Endologix disclosed that the FDA has requested the company to provide a two-year patient follow-up data from the EVAS-FORWARD IDE study of Nellix System.

  • [By Paul Ausick]

    Endologix Inc. (NASDAQ: ELGX) dropped about 9.3% on Wednesday to post a new 52-week low of $4.78 against a 52-week high of $14.50 and a Tuesday close of $5.27. Volume of about 6 million was more than 3 times the daily average of around 1.7 million. The company on Tuesday announced a temporary shipping hold on its best-selling heart device, saying there was a manufacturing issue.

top stocks invest now: Ideal Power Inc.(IPWR)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewslettersuggested smallcap electrical power conversion product stock Ideal Power Inc (NASDAQ: IPWR)as a long trade:

top stocks invest now: Gaming and Leisure Properties, Inc.(GLPI)

Advisors’ Opinion:

  • [By Monica Gerson]

    Gaming and Leisure Properties Inc (NASDAQ: GLPI) shares fell 3.25 percent to $31.90 in pre-market trading. Gaming and Leisure Properties priced offering of 10.53 million shares of common stock for gross proceeds of $333 million.

  • [By Seth McNew]

    One way Penn has been able to unlock extra value is by spinning off a portion of operations as a real estate investment trust (REIT) as a way to split up the physical property from the gaming operations. Following that 2013 creation of Gaming and Leisure Properties Inc(NASDAQ:GLPI),Penn essentially pays leasing fees to the REIT so it can focus on operations with a leaner balance sheet. Here’s a more in-depth analysis of the upside of Penn’s REIT model.

top stocks invest now: Iridium Communications Inc(IRDM)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap satellite stock Iridium Communications (NASDAQ: IRDM) reportedQ2 2017 earnings before the market opened on Thursday with results beating expectations. Total revenueincreased 2% to $111.6 million which consisted of $86.6 million of service revenue and $25.0 million of revenue related to equipment sales and engineering and support projects.Service revenue, which represents primarily recurring revenue from Iridium’s growing subscriber base, grew 4% and was 78% of total revenue. The Company ended the quarter with 913,000 total billable subscribers, which compares to 823,000 for the year-ago period and is up from 869,000 for the quarter ended March 31, 2017.Total billable subscribers grew 11% year-over-year, driven by growth in M2M and government customers. Net income was $24.8 million versus $26.9 million for the second quarter of 2016. The CEO commented:

  • [By Jim Robertson]

    Trump’s proposal to spin off air traffic control from the Federal Aviation Administration (FAA) bodes well for small cap satellite stock Iridium Communications (NASDAQ: IRDM), but theres a bigger opportunity for the Company in theInternet of Things (IoT) space. Technology company Harris Corporation (NYSE: HRS) is already a leading candidate to supply the FAA with real-time aircraft tracking data in partnership with Iridium Communications with the latter having a joint venture that has partnered with air traffic control authorities in Canada, Italy, Ireland and Denmark to provide air traffic surveillance (in cooperation with Harris).

top stocks invest now: Nu Skin Enterprises Inc.(NUS)

Advisors’ Opinion:

  • [By Craig Jones]

    Nu Skin Enterprises, Inc. (NYSE: NUS) is trading sharply higher on Friday, but options traders are buying puts in the name, said Jon Najarian. Traders were buying the June 50 puts and they paid around 6 percent for them, so they don't see much upside in Nu Skin Enterprises, explained Najarian. He followed the trade and he is planning to hold the position for a month.

  • [By Roberto Pedone]

    Nu Skin Enterprises (NUS) is a direct selling company, which develops and distributes personal care products and nutritional supplements that are sold under the Nu Skin and Pharmanex brands. This stock closed up 5.4% at $92.96 in Monday’s trading session.

    Monday’s Volume: 2 million

    Three-Month Average Volume: 900,802

    Volume % Change: 85%

    From a technical perspective, NUS ripped higher here right above some near-term support at $85 with heavy upside volume. This move pushed shares of NUS into breakout and new 52-week-high territory, since the stock took out some near-term overhead resistance levels at $88.20 to $89.69. This move also pushed shares of NUS above the upper-end of its recent range that saw the stock trend between $82 to just above $89.

    Traders should now look for long-biased trades in NUS as long as it’s trending above support at $85 and then once it sustains a move or close above Monday’s high of $93.33 with volume that this near or above 900,802 shares. If we get that move soon, then NUS will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $100 to $105.

  • [By Scott Rubin]

    Stock gainers included Mercadolibre Inc (NASDAQ: MELI), up almost 14 percent, and Nu Skin Enterprises, Inc. (NYSE: NUS), which added 12 percent. The positive gains in both stocks were due to strong earnings reports. Shares of Liberty Interactive Group (NASDAQ: QVCA) plunged almost 22 percent on Friday due to disappointing sales growth in its fiscal second quarter. Pharmaceutical giant Bristol-Myers Squibb Co (NYSE: BMY) lost 16 percent after a disappointing study involving its Opdivo drug.

  • [By Ben Levisohn]

    Citigroup’s Beth Kite calls Nu Skin Enterprises’ (NUS) earnings and guidance “awfully disappointing.” She explains why:

    “Frustrating” Describes 4Q15 & 2016 Guidance:Nu Skin (i) reported 4Q15 EPS of $0.62, 11 cents below consensus and us, and (ii) lowered 2016 EPS guidance, from $3.25-$3.40 to $2.40-$2.60.Nu Skin had three LTO’s in 4Q152 succeeded and 1 failed. The failure had far less to do with the product than with the sales strategy…

    Is Guidance Too Conservative or Is It Really This Bad? We get that Me failed to sell well in South Korea with the 12-month cartridge commitment. But given the strength in reps globally, the strength of Youth from its two LTOs in 2H15, and good results from Me when sold in Japan without the 12-month commitment, we wonder if guidance is aggressive to the downside. Indeed, the word “conservative” was said a lot by mgmt on the brief earnings call when describing guidance revisions.

    Maintaining Buy: While we now have less confidence in mgmt, from an external perspective, to forecast its results accurately, and from an internal perspective, to course correct quicklyi.e., why didn’t they drop the 12-month plan for Me in South Korea when it so obviously wasn’t workingwe are still confident in Youth & Me. The rep growth in South Asia/Pacific from Youth in 3Q led to better 4Q sales than we’d expected, Youth’s Americas LTO in 4Q drove lc sales up 26% YoY, and Me not only sold through in Japan in 4Q but also drove reps higher. We imagine that investors may have little patience or confidence in Nu Skin for a while, understandably. But the bar seems set fairly low now, so we are cautiously optimistic that Nu Skin can dig itself out of this hole as we go through 2016 and Me & Youth roll out more fully.

    Shares of Nu Skin have tumbled 13% to $27.31 at 2:11 p.m. today.

top stocks invest now: United States Steel Corporation(X)

Advisors’ Opinion:

  • [By Lisa Levin]

    Basic materials shares rose by 0.74 percent in the US market on Friday. Top gainers in the sector included AK Steel Holding Corporation (NYSE: AKS), Cliffs Natural Resources Inc (NYSE: CLF), and United States Steel Corporation (NYSE: X).

  • [By Lee Jackson]

    These companies also reported insider buying last week: Apache Corp. (NYSE: APA), Halliburton Co. (NYSE: HAL), Revlon Inc. (NYSE: REV), Valeant Pharmaceuticals International Inc. (NYSE: VRX) and U.S. Steel Corp. (NYSE: X).

  • [By Rafi Farber]

    While United States Steel Corp. (NYSE: X) has clear and obvious benefits from a Trump presidency, it has already climbed over 35% since election day and has blown by 12-month consensus estimates of $22.5 a share by 27%. If Trump has been vocal about anything consistently, it has been his intention to slap tariffs on Chinese imports, with specific emphasis on Chinese steel dumping which he thinks hurts America, even though Americans are the ones choosing to buy it freely.

  • [By Spencer Israel]

    The following are some of the stocks discussed on the show for which co-host Joel Elconin offered technical levels.

    Bank of America Corp (NYSE: BAC) hit a low last week of $22.43, and has a big psychological level of $22.
    Goldman Sachs Group Inc (NYSE: GS) has two minor support levels from early December of $221.22 and $220.35. Under $220 it gets dicey, with support at $214.97 and $209.92.
    United States Steel Corporation (NYSE: X) has a key low of $31.33 from February 2. That number serves as support.
    Best Buy Co Inc (NYSE: BBY) has a triple top at $45.15. It's currently in a trading range from $43.75-$45.70.
    Shake Shack Inc (NYSE: SHAK) has been range bound over the last four days from $31.68 to $32.62. It has major support at the all-time low from March 15 at $30.36.
    Warren Lorenz, CEO of TechMeetsTrader, joined the show to discuss his "Facebook for stocks" platform, and how he learned how to trade by watching trading communities. Listen to the full interview with Lorenz here.
    Tommy Lackey, managing partner and portfolio manager at Relativity Capital Advisors, told us which stocks are on his nitrous scans and meltdown filters this morning. Those include XOMA Corporation (NASDAQ: XOMA) Whirlpool Corporation (NYSE: WHR) and Bed Bath & Beyond Inc. (NASDAQ: BBBY). Listen to the full interview with Lackey here.
    With the market in a slight selloff following Friday's healthcare fallout, the focus today will be which sectors, if any, rebound throughout the day. With steel stocks looking weak and gold minors and utilities looking strong, co-host Dennis Dick said he'll try to jump into those sectors if they stay weak after the open. Hear what other sectors Dick is watching here.
    With Snap Inc (NYSE: SNAP)'s 25-day quiet period for analysts over, the Street was treated to bullish ratings by Goldman Sachs, Citigroup, Morgan Stanley and others. It's worth noting, however, most of Monday morning

Top 10 Canadian Stocks To Watch For 2018

In the endless flow of millennial-focused surveys, one finally stuck out to me.

It came via email from Canadian firm RBC Wealth Management, which found that when it comes to money, millennials are more confident and prepared than previous generations. We feel responsible for understanding our financial affairs and do research to improve our financial knowledge, the survey reported.

I believe all of this is true, which is why I initially overlooked that this survey wasn’t actually about a group to which I belong: It was solely focused on high net worth millennials, specifically 479 respondents under age 35 with average investable assets of $5.7 million. The majority in this group expect to receive an inheritance, if they haven’t already.

Credit: Shutterstock

So: Rich millennials with rich parents are doing great — financially speaking, anyway. What about the rest of us?

Top 10 Canadian Stocks To Watch For 2018: Nu Skin Enterprises Inc.(NUS)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Citigroup’s Beth Kite calls Nu Skin Enterprises’ (NUS) earnings and guidance “awfully disappointing.” She explains why:

    “Frustrating” Describes 4Q15 & 2016 Guidance:Nu Skin (i) reported 4Q15 EPS of $0.62, 11 cents below consensus and us, and (ii) lowered 2016 EPS guidance, from $3.25-$3.40 to $2.40-$2.60.Nu Skin had three LTO’s in 4Q152 succeeded and 1 failed. The failure had far less to do with the product than with the sales strategy…

    Is Guidance Too Conservative or Is It Really This Bad? We get that Me failed to sell well in South Korea with the 12-month cartridge commitment. But given the strength in reps globally, the strength of Youth from its two LTOs in 2H15, and good results from Me when sold in Japan without the 12-month commitment, we wonder if guidance is aggressive to the downside. Indeed, the word “conservative” was said a lot by mgmt on the brief earnings call when describing guidance revisions.

    Maintaining Buy: While we now have less confidence in mgmt, from an external perspective, to forecast its results accurately, and from an internal perspective, to course correct quicklyi.e., why didn’t they drop the 12-month plan for Me in South Korea when it so obviously wasn’t workingwe are still confident in Youth & Me. The rep growth in South Asia/Pacific from Youth in 3Q led to better 4Q sales than we’d expected, Youth’s Americas LTO in 4Q drove lc sales up 26% YoY, and Me not only sold through in Japan in 4Q but also drove reps higher. We imagine that investors may have little patience or confidence in Nu Skin for a while, understandably. But the bar seems set fairly low now, so we are cautiously optimistic that Nu Skin can dig itself out of this hole as we go through 2016 and Me & Youth roll out more fully.

    Shares of Nu Skin have tumbled 13% to $27.31 at 2:11 p.m. today.

  • [By Craig Jones]

    Nu Skin Enterprises, Inc. (NYSE: NUS) is trading sharply higher on Friday, but options traders are buying puts in the name, said Jon Najarian. Traders were buying the June 50 puts and they paid around 6 percent for them, so they don't see much upside in Nu Skin Enterprises, explained Najarian. He followed the trade and he is planning to hold the position for a month.

  • [By Roberto Pedone]

    Nu Skin Enterprises (NUS) is a direct selling company, which develops and distributes personal care products and nutritional supplements that are sold under the Nu Skin and Pharmanex brands. This stock closed up 5.4% at $92.96 in Monday’s trading session.

    Monday’s Volume: 2 million

    Three-Month Average Volume: 900,802

    Volume % Change: 85%

    From a technical perspective, NUS ripped higher here right above some near-term support at $85 with heavy upside volume. This move pushed shares of NUS into breakout and new 52-week-high territory, since the stock took out some near-term overhead resistance levels at $88.20 to $89.69. This move also pushed shares of NUS above the upper-end of its recent range that saw the stock trend between $82 to just above $89.

    Traders should now look for long-biased trades in NUS as long as it’s trending above support at $85 and then once it sustains a move or close above Monday’s high of $93.33 with volume that this near or above 900,802 shares. If we get that move soon, then NUS will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $100 to $105.

  • [By Scott Rubin]

    Stock gainers included Mercadolibre Inc (NASDAQ: MELI), up almost 14 percent, and Nu Skin Enterprises, Inc. (NYSE: NUS), which added 12 percent. The positive gains in both stocks were due to strong earnings reports. Shares of Liberty Interactive Group (NASDAQ: QVCA) plunged almost 22 percent on Friday due to disappointing sales growth in its fiscal second quarter. Pharmaceutical giant Bristol-Myers Squibb Co (NYSE: BMY) lost 16 percent after a disappointing study involving its Opdivo drug.

Top 10 Canadian Stocks To Watch For 2018: PPL Corporation(PPL)

Advisors’ Opinion:

  • [By Paul Ausick]

    PPL Corp. (NYSE: PPL) posted a 52-week low of $31.53 after closing Tuesday at $32.42. The 52-week high is $40.20. Volume was about 15.5 million, more than three times the daily average of around 4 million shares. The electric utility company took a downgrade on Tuesday and the fallout continues to drop.

  • [By Paul Ausick]

    PPL Corp. (NYSE: PPL) posted a 52-week low of $31.11 after closing Wednesday at $31.59. The 52-week high is $40.20. Volume was about 9.6 million, more than double the daily average of around 4.2 million shares. The electric utility company had no specific news.

  • [By Paul Ausick]

    PPL Corp. (NYSE: PPL) posted a 52-week low of $30.81 after closing Friday at $31.13. The 52-week high is $40.20. Volume was about 3.5 million, about 25% below the daily average of around 4.5 million shares. The electric utility company had no specific news.

  • [By Paul Ausick]

    PPL Corp. (NYSE: PPL) posted a 52-week low of $32.48 after closing Monday at $33.97. The 52-week high is $40.20. Volume was about 5.9 million, nearly a third higher than the daily average of around 3.9 million shares. The electric utility company had no specific news.

Top 10 Canadian Stocks To Watch For 2018: Rhino Resource Partners LP(RNO)

Advisors’ Opinion:

  • [By Alexis Xydias]

    Investors are regaining confidence, squeezing pessimists who say the economy remains sluggish outside of Germany and point to record-low trading volume as a lack of conviction in the Euro Stoxxs 61 percent rally of the past two years. Besides gains in stocks from Banco Bilbao Vizcaya Argentaria SA to Renault SA (RNO), yields on Spanish and Italian bonds have declined to a two-year low compared with German bunds and the euro has strengthened 4.6 percent to $1.35 in the past six months.

Top 10 Canadian Stocks To Watch For 2018: Thor Industries Inc.(THO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Thor Industries, Inc. (NYSE: THO) got a boost, shooting up 14 percent to $102.70 as the company reported stronger-than-expected results for its first quarter on Monday.

  • [By Peter Graham]

    A long term performance chart shows shares of Winnebago Industriesalong withmid cap peers Thor Industries, Inc (NYSE: THO) and LCI Industries (NYSE: LCII) all giving a very similar performance and largely taking off starting in 2016:

  • [By Peter Graham]

    A long term performance chart shows shares of Winnebago Industries and small cap peer Thor Industries, Inc (NYSE: THO) giving a similar performance with shares taking off last year before stumbling this year while Drew Industries, Inc (NYSE: DW) has mostly underperformed:

  • [By WWW.THESTREET.COM]

    In his second “Executive Decision” segment, Cramer spoke with Bob Martin, president and CEO of Thor Industries (THO) , a stock that was crushed today, down 9.8%, on a penny-a-share earnings beat with tempered guidance.

Top 10 Canadian Stocks To Watch For 2018: NRG Energy Inc.(NRG)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was NRG Energy, Inc. (NYSE: NRG) which rose over 5% to $22.20. The stocks 52-week range is $9.84 to $23.36. Volume was over 35 million compared to its average volume of 5.8 million.

  • [By Ben Levisohn]

    NRG Energy (NRG) has gained 2.1% to $18.49 after getting raise to Buy from Neutral at Goldman Sachs.

    Skechers USA (SKX) has tumbled 5.4% to$28.35 after getting cut to Negative from Positive at Susquehanna.

  • [By Craig Jones]

    Pete Najarian said that there was a big options activity in NRG Energy Inc (NYSE: NRG). Traders were aggressively buying the October 26 calls. Around 6,000 contracts were traded in the first half of the session and they were paying 65 cents for them. The trade breaks even at $26.65 or more than 11 percent above the current market price.

  • [By Lisa Levin]

    In trading on Wednesday, utilities shares fell 0.25 percent. Meanwhile, top losers in the sector included NRG Energy Inc (NYSE: NRG), down 3 percent, and Entergy Corporation (NYSE: ETR) down 1 percent.

  • [By Lisa Levin]

    Non-cyclical consumer goods & services sector was the top gainer in the US market on Wednesday. Top gainers in the sector included Cia Energetica de Minas Gerais CEMIG-ADR (NYSE: CIG), Companhia Paranaense de Energia (ADR) (NYSE: ELP), and NRG Energy Inc (NYSE: NRG).

Top 10 Canadian Stocks To Watch For 2018: 3M Company(MMM)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Who are the likely candidates for the next round of upgrades? Cramer said he’s betting that 3M (MMM) will be in the mix, along with Walmart (WMT) and especially Home Depot (HD) , which should have a strong spring planting season with good comparisons to last year. Investors might also see upgrades on Honeywell (HON) and Nike (NKE) , Cramer suggested.

  • [By Paul Ausick]

    3M Company (NYSE: MMM) traded down 1.69% at $230.78. The stock’s 52-week range is $163.85 to $238.90. Volume was about equal to the daily average of around 1.7 million. The company had no specific news Monday.

  • [By Paul Ausick]

    3M Company (NYSE: MMM) traded down 1.05% at $210.38. The stock’s 52-week range is $163.85 to $214.57. Volume was about 20% below the daily average of around 1.8 million. The company had no specific news.

Top 10 Canadian Stocks To Watch For 2018: Valeant Pharmaceuticals International Inc(VRX)

Advisors’ Opinion:

  • [By Kumar Abhishek]

    2017 has turned out to be a good year for Valeant Pharmaceuticals Intl Inc(NYSE:VRX) so far. Shares of thespecialty pharma company have been on atear of late. Valeant stock has gained more than 25% since the end of January compared to over 3% gain in Nasdaq Composite (INDX:COMPX). The stock has gained more than 10% in the last two days. Valeant stock is up another 5% in the pre-market trade today on the news that FDA has approved “Siliq” (orbrodalumab as it was previously known), a drug marketed by Valeant to treat adults with moderate-to-severe plaque psoriasis.

  • [By Ben Levisohn]

    If it feels like it’s been all Valeant Pharmaceuticals International (VRX) today, I get it, and I promise this will be my last post on the company today. But really, how often do we get to see a fund manager acknowledge a spectacular mistake in such publicfashion?

    Photo: Andrew Harrer/Bloomberg

    As if it weren’t obvious yet, Ackman’s exit is bad news for the stock.Yes, some analysts have tried to focus on other issues that could be positive, but, really, as long as Ackman was around, you knew someone big had Valeant’s back. And now he’s gone. We at Barron’s were never too enthusiastic about Valeant–Vito Racanelliwrote bearishly on the company 2014–or Ackman’s involvement. But it he was your reason to be in Valeant, well consider what Wells Fargo analyst David Maris has to say:

    …we believe investors will take Pershing Squares exit as a reflection that 1) the outlook is negative; 2) the potential for meaningful near-term asset sales is unlikely; 3) the legal proceedings/investigations may have greater risk than the Street is appreciating; 4) a turnaround will take longer than expected or is not possible; and 5) the debtholders have an advantaged position in the capital structure, and as such the equity holders are at their mercy, especially in a bankruptcy situation. We believe investors would consider this as a sign that the next several years may not represent a major turnaround for the company.

    Shares of Valeant have dropped 11% to$10.76 at 3:12 p.m.

  • [By Kumar Abhishek]

    Valeant Pharmaceuticals Intl Inc(NYSE:VRX) stock has been rallying going into this earningsseason. Valeant stock is up by more than 20% since the beginningof February. VRX stock is currently facing resistance from the100-day simple moving average trendline. The run in the stock has been driven by the FDA approval of “Saliq”, a drug marketed by Valeant to treat adults with moderate-to-severe plaque psoriasis, and the company’s asset sales plans. Valeant has announcedasset sales of more than $2.5 billion since the beginning of the year. These asset sales will help in paring down some portion of Valeant’s $30 billion debt which is holding down the stock.

  • [By Paul Ausick]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped about 2.4% Monday to post a new 52-week low of $8.31 after closing Friday at $8.51. The stock’s 52-week high is $38.50. Volume of around 13.5 million shares was about 65% below the daily average of around 18.8 million. The company had no specific news, and shares are on track to add about 1.5% by the closing bell.

  • [By Paul Ausick]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped about 2.7% Tuesday, to post a new 52-week low of $10.35 after closing at $10.64 on Monday. The stock’s 52-week high is $38.50. Volume was nearly equal to the daily average of around 18.6 million shares. The battered drug maker completed a $1.1 billion bond tender offer as investors couldn’t wait to cash out.

Top 10 Canadian Stocks To Watch For 2018: Plains All American Pipeline L.P.(PAA)

Advisors’ Opinion:

  • [By Dustin Parrett]

    Plains All American Pipeline (NYSE: PAA) controls 4 million barrels of crude oil and natural gas a day.

    And with higher oil prices and fewer restrictions leading to more drilling, PAA’s pipelines will be in demand in 2017.

  • [By Dustin Parrett]

    We think Plains All American Pipeline L.P. (NYSE: PAA) is one of the best oil stocks to buy this year. In fact, we see a scenario where PAA stock could jump 20% in 2017.

  • [By Matthew DiLallo]

    One of the largest projects is the Saddlehorn Pipeline, which Magellan is building with Plains All American Pipeline (NYSE:PAA) and Anadarko Petroleum (NYSE:APC). Both Plains All American Pipeline and Magellan own 40% of the project, which puts their total investment at $230 million apiece. They expect the project to be fully operational early next year, which is noteworthy given its robust first-year economics. Magellan estimates that it will earn eight times EBITDA on the capital deployed, or roughly $28.8 million in annual EBITDA apiece for Magellan and Plains All American Pipeline on their investment.

Top 10 Canadian Stocks To Watch For 2018: Transcananda Pipelines Ltd.(TRP)

Advisors’ Opinion:

  • [By WWW.KIPLINGER.COM]

    Energy stocks were driven by a hefty dose of M&A during the third quarter. And that will drive returns for TransCanada Corporation (TRP) during the next one.

  • [By Ben Levisohn]

    In a number of articles recently, following the US recent revival and potential approval of the previously blocked Keystone XL pipeline, a number of estimates have been provided suggesting a pending boom for the US steel industry is on the horizon (and US steel stocks have reacted in kind). In fact, this optimism, we believe, peaked today when a report from one of our competitors was published claiming that, the keystone XL pipeline could increase line pipe demand by 14.7% for 2 years. The problem here, we believe, rests with the facts that: (a) TransCanada (TRP) has already taken, and paid for, the steel to build the Keystone XL pipeline (the steel currently sits in storage facilities in both Regina, Canada and Arkansas, United States), (b) neither US Steel (X; SELL), AK Steel, Steel Dynamics, or Nucor have the ability to make the specialized steel required for the miles of pipe associated with this project, to include both the thickness and pressure requirements, according to this article from Reuters, and (c) assuming some of the pipe does need replacement, this would likely come from international steel makers who are capable of producing the specialized steel (again, as highlighted in this Reuters article).

  • [By Matthew DiLallo]

    After a series of setbacks in its attempts to build new oil pipelines, Canadian pipeline giant TransCanada (NYSE:TRP) completed a transformation transaction to acquire U.S. natural gas pipeline company Columbia Pipeline Group for $13 billion, which includes the assumption of debt. The key to that deal was that it increased the combined company’s near-term project pipeline to 23 billion Canadian dollars, which supports TransCanada’s ability to increase its dividend by 8% to 10% annually through 2020. After completing that deal, TransCanada made a bid to acquire all of the outstanding units that it did not own of affiliated MLP Columbia Pipeline Partners (NYSE:CPPL) in a transaction valued at $915 million. These acquisitions solidified TransCanada’s natural gas pipeline growth ambitions, enabling it to diversify away from oil pipelines.

  • [By Paul Ausick]

    That includes pipeline companies like Kinder Morgan Inc. (NYSE: KMI), which already operates a pipeline transporting natural gas from Texas into Mexico, and master limited partnerships (MLPs) Energy Transfer Partners L.P. (NYSE: ETP) and TransCanada Corp. (NYSE: TRP), the company that has (so far) failed to get U.S. approval for its Keystone Pipeline expansion from Canada’s oil sands across the U.S. border.

Top 10 Canadian Stocks To Watch For 2018: NEW GOLD INC.(NGD)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market lost ground on Monday, sending major market benchmarks lower by more than half a percentage point. The Dow lost its grip on the 20,000 mark in the wake of concerns about economic growth and new U.S. immigration policy, and some believe that the broader geopolitical climate could have a negative impact on global commerce that in turn could start affecting multinational corporations’ business prospects. In addition, bad news from some individual companies weighed on the markets, and Transocean (NYSE:RIG), Rite Aid (NYSE:RAD), and New Gold (NYSEMKT:NGD) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

Best Canadian Stocks For 2018

Related VRX Worst Stocks Of The First Quarter Valeant In Breach Of Canadian Regulations Dependent on Fridays Data – March 30 2016 (Marketfy Insights)

A pair of top Wall Street firms aren’t on the same page when it comes to the outlook for Valeant Pharmaceuticals Intl Inc (NYSE: VRX) senior notes. In a March 21 report, Citi analyst Murali Ganti said that the resignation of CEO Michael Pearson and the addition of Bill Ackman to the board of directors should go a long way in stabilizing the volatile stock. In addition, Citi sees plenty of value in Valeant debt.

Best Canadian Stocks For 2018: Chipotle Mexican Grill Inc.(CMG)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Sometimes it’s a little subtle. Take Chipotle (CMG) . The numbers looked terrible, but if you had followed the company’s numbers trajectory, you would have realized that the company is seeing the beginning of the turn in business that we’ve been forecasting.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Tuesday was Chipotle Mexican Grill, Inc. (NYSE: CMG) which jumped 2.8% to $407.45. The stocks 52-week range is $352.96 to $481.63. Volume was 1.1 million which is above the daily average of around 853,000 shares.

  • [By Peter Graham]

    A long term performance chart shows El Pollo LoCo Holdings stabilizing over thepast two yearswhile potentialpeers like large cap Chipotle Mexican Grill, Inc (NYSE: CMG) andsmall capsFiesta Restaurant Group Inc (NASDAQ: FRGI) and Chuy’s Holdings Inc (NASDAQ: CHUY)have performed better in the past and appear to be in downtrends for the past 1 1/2 years:

  • [By Dan Caplinger, Tim Brugger, and Seth McNew]

    Risk is always a factor for stock market investors, but if you want the top stocks in your portfolio, you have to be bold. To give you some ideas on which stocks to look at, three Motley Fool contributors weighed in on companies they’re familiar with and made a case for why they deserve a closer look. Read on to learn more about Shopify (NYSE:SHOP), Chipotle Mexican Grill (NYSE:CMG), and Universal Display (NASDAQ:OLED) and why they deserve your attention.

Best Canadian Stocks For 2018: Natural Gas(NG)

Advisors’ Opinion:

  • [By James E. Brumley]

    When an investor thinks of Canadian gold mining stocks, NovaGold Resources Inc. (USA) (NYSEMKT:NG) and Yamana Gold Inc. (USA) (NYSE:AUY) are often the first names to come to mind. And well they should. Yamana Gold is a $2.5 billion giant, and NovaGold Resources seems to have been around forever.

    Those two icons aren’t the only way to tap into Canada’s sizeable gold mining industry though. There’s a small, up-and-coming player called Taranis Resources Inc. (OTCMKTS:TNREF, TSX:TRO) that could end up becoming another key fixture of the country’s mining landscape.

    Taranis develops mineral deposits into mine-ready projects. Its primary project right now — and it’s enough to keep the company plenty busy for the next several years — is the Thor property located near Trout Lake, British Columbia. NI 43-101 resource reports (indicated and inferred)suggest Thor contains 6.9 million ounces of silver, 35,000 ounces gold, 57 million pounds of lead, 79.4 million pounds of zinc and 3.3 Million pounds of copper (roughly a 14 million ounce silver equivalent (“AgEq”) deposit*) laying in wait in a way that lends itself to the establishment of a low-cost, open pit mining operation. That’s roughly $300 million worth of marketable metals, and the estimates have been steadily getting bigger as Tanaris does more survey work.

    And 2017 could be a real breakout year for Taranis, as a lot of the work that’s been done to date starts to mean something. It’s got big exploration plans for this year… this spring/summer to be exact.

    The Phase 1 program was completed in September of last year, setting the stage for a more defined and much bigger Phase 2 definition-drilling within the next several weeks. This Phase 2 definition drilling slated for the middle of this year will drill down to between 6000 m and 10,000 m.

    These so-called first generation target areas are generally well understood areas based on sound geological information includ

  • [By Money Morning Staff Reports]

    Canadian gold mining company NovaGold Resources Inc. (NYSE: NG) shows an even starker change in sentiment. In the last 12 months, the volume of short bets on the stock declined 79%, to 522,400.

  • [By William Romov]

    Over the last year, the number of short positions on gold stocks has fallen. One of these stocks is a Canadian gold mining company called NovaGold Resources Inc. (NYSE: NG). In the last 12 months, the volume of short bets on the stock declined 79%, to 522,400. This shows a shift in sentiment from bearish to bullish for gold.

Best Canadian Stocks For 2018: Nu Skin Enterprises Inc.(NUS)

Advisors’ Opinion:

  • [By Scott Rubin]

    Stock gainers included Mercadolibre Inc (NASDAQ: MELI), up almost 14 percent, and Nu Skin Enterprises, Inc. (NYSE: NUS), which added 12 percent. The positive gains in both stocks were due to strong earnings reports. Shares of Liberty Interactive Group (NASDAQ: QVCA) plunged almost 22 percent on Friday due to disappointing sales growth in its fiscal second quarter. Pharmaceutical giant Bristol-Myers Squibb Co (NYSE: BMY) lost 16 percent after a disappointing study involving its Opdivo drug.

  • [By Craig Jones]

    Nu Skin Enterprises, Inc. (NYSE: NUS) is trading sharply higher on Friday, but options traders are buying puts in the name, said Jon Najarian. Traders were buying the June 50 puts and they paid around 6 percent for them, so they don't see much upside in Nu Skin Enterprises, explained Najarian. He followed the trade and he is planning to hold the position for a month.

  • [By Ben Levisohn]

    Citigroup’s Beth Kite calls Nu Skin Enterprises’ (NUS) earnings and guidance “awfully disappointing.” She explains why:

    “Frustrating” Describes 4Q15 & 2016 Guidance:Nu Skin (i) reported 4Q15 EPS of $0.62, 11 cents below consensus and us, and (ii) lowered 2016 EPS guidance, from $3.25-$3.40 to $2.40-$2.60.Nu Skin had three LTO’s in 4Q152 succeeded and 1 failed. The failure had far less to do with the product than with the sales strategy…

    Is Guidance Too Conservative or Is It Really This Bad? We get that Me failed to sell well in South Korea with the 12-month cartridge commitment. But given the strength in reps globally, the strength of Youth from its two LTOs in 2H15, and good results from Me when sold in Japan without the 12-month commitment, we wonder if guidance is aggressive to the downside. Indeed, the word “conservative” was said a lot by mgmt on the brief earnings call when describing guidance revisions.

    Maintaining Buy: While we now have less confidence in mgmt, from an external perspective, to forecast its results accurately, and from an internal perspective, to course correct quicklyi.e., why didn’t they drop the 12-month plan for Me in South Korea when it so obviously wasn’t workingwe are still confident in Youth & Me. The rep growth in South Asia/Pacific from Youth in 3Q led to better 4Q sales than we’d expected, Youth’s Americas LTO in 4Q drove lc sales up 26% YoY, and Me not only sold through in Japan in 4Q but also drove reps higher. We imagine that investors may have little patience or confidence in Nu Skin for a while, understandably. But the bar seems set fairly low now, so we are cautiously optimistic that Nu Skin can dig itself out of this hole as we go through 2016 and Me & Youth roll out more fully.

    Shares of Nu Skin have tumbled 13% to $27.31 at 2:11 p.m. today.

  • [By Roberto Pedone]

    Nu Skin Enterprises (NUS) is a direct selling company, which develops and distributes personal care products and nutritional supplements that are sold under the Nu Skin and Pharmanex brands. This stock closed up 5.4% at $92.96 in Monday’s trading session.

    Monday’s Volume: 2 million

    Three-Month Average Volume: 900,802

    Volume % Change: 85%

    From a technical perspective, NUS ripped higher here right above some near-term support at $85 with heavy upside volume. This move pushed shares of NUS into breakout and new 52-week-high territory, since the stock took out some near-term overhead resistance levels at $88.20 to $89.69. This move also pushed shares of NUS above the upper-end of its recent range that saw the stock trend between $82 to just above $89.

    Traders should now look for long-biased trades in NUS as long as it’s trending above support at $85 and then once it sustains a move or close above Monday’s high of $93.33 with volume that this near or above 900,802 shares. If we get that move soon, then NUS will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $100 to $105.

Best Canadian Stocks For 2018: Patni Computer Systems Limited(PTI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Proteostasis Therapeutics Inc (NASDAQ: PTI) shares shot up 162 percent to $6.16 after the company disclosed 'positive' PTI-428 data with statistical significance.

  • [By William Romov]

    Before we show you our pick, here are the top 10 penny stocks to watch this week

    Penny Stock Current Share Price Nov. 27-Dec. 1 Gain (as of Dec. 1)
    Pyxis Tankers Inc. (Nasdaq: PXS) $4.10 122.83%
    Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.28 68.42%
    Cerecor Inc. (Nasdaq: CERC) $1.74 47.46%
    Proteostasis Therapeutics Inc. (Nasdaq: PTI) $2.52 37.71%
    UT Starcom Holdings Corp. (Nasdaq: UTSI) $5.20 37.20%
    WMIH Corp. (Nasdaq: WMIH) $0.96 33.46%
    PhaseRx Inc. (Nasdaq: PZRX) $0.90 30.29%
    Bellerophon Therapeutics Inc. (Nasdaq: BLPH) $2.04 29.94%
    EV Energy Partners LP (Nasdaq: EVEP) $0.86 27.76%
    Catalyst Pharmaceuticals Inc. (Nasdaq: CPRX) $4.40 25.71%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, its completely free

Best Canadian Stocks For 2018: Silver Wheaton Corp(SLW)

Advisors’ Opinion:

  • [By Rich Duprey]

    Silver Wheaton (NYSE:SLW), of course, is a streamer like Sandstorm and Franco, but it is the largest in the precious-metals industry, and arguably the best-known, because its business model came to define what streaming is. Although it is known primarily for its silver contracts, Silver Wheaton also has sizable gold production that makes it worth your attention.

Top Canadian Stocks To Buy For 2018

Introduction – Railroads as an Investment Option

Railroads – many of us cross over tracks everyday on our commute to work each day and some of us actually taking a train on a daily basis perhaps. Railroads have been around for a long time, moving all sorts of cargo from coast to coast. Railroad stocks took it on the chin not too long ago due to coal weakening and oil production being cut in conjunction with increased utilization of pipelines to transport gas and oil, but public railroad stocks can be an exceptional investment option in a growing economy as they move many materials and goods. They may not be an exciting investment but they sure can be effective – take a look at the chart below. Over the past five years, Union Pacific Corporation (NYSE:UNP), CSX Corporation (NYSE:CSX), and Canadian National Railway Company (NYSE:CNI) have all outperformed the S&P by as much as 58%.

Top Canadian Stocks To Buy For 2018: ConocoPhillips(COP)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    Phillips 66 is a multi-national company headquartered in Westchase, Houston. It was spun off from ConocoPhillips (NYSE: COP) in 1917.

    Stock Return (Since 2012): 144.1 percent.

  • [By WWW.THESTREET.COM]

    The contract awards are for the jack-ups West Elara and West Linus with ConocoPhillips Skandinavia AS (COP) for work in the Greater Ekofisk area. The total additional backlog for the new contract awards is estimated to be about $1.4 billion, excluding performance bonuses.

  • [By WWW.THESTREET.COM]

    ConocoPhillips (COP) was upgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: COP.

    Urban Outfitters (URBN) was downgraded to market perform at William Blair. Continued comp-store sales pressure is pushing out the timeline for a potential recovery, Blair said. 

  • [By Dustin Parrett]

    Big Oil stocks are the seven “oil supermajors” that do everything from oil drilling to refining to retail sales. This is a list of the Big Oil companies:

    Big Oil CompanyShare PriceYTDMarket CapExxon Mobil Corp. (NYSE: XOM)$83.44-7.58%$353.13BChevron Co. (NYSE: CVX)$113.56-3.5%$217.62BConocoPhillips Co. (NYSE: COP)$48.21-3.78%$61.42BRoyal Dutch Shell Plc. (NYSE ADR: RDS.A)$52.35-3.82%$221.08BBP Plc. (NYSE ADR: BP)$34.12-8.71%$112.69BTotal SA (NYSE: TOT)$50.26-1.35%$124.6BEni SpA (NYSE: E)$31.51-2.3%$58.69B

    Despite being huge global oil companies, shares of Big Oil stocks are all in the red this year. Those losses have all happened even as the Dow is smashing record highs and trading up 6.4% year to date.

  • [By WWW.KIPLINGER.COM]

    Spun off from energy producer ConocoPhillips (COP) a few years back, PSX has quickly become one of the downstream industrys biggest players. Refiners earn profits based on the difference between feed stock costs (Think oil and natural gas prices) and the price for refined products such as gasoline, jet fuel and heating oil. Those inputs remain low, and Phillips 66 is minting cash as a result.

Top Canadian Stocks To Buy For 2018: Wells Fargo & Company(WFC)

Advisors’ Opinion:

  • [By WWW.KIPLINGER.COM]

    Cliches aside, Wells Fargo & Co. (WFC) might not be the most popular name after its phony accounts scandal, but so what? Its still a quality business with a quality stock that yields 3.4%.

  • [By JPMorgan]

    We recommend Wells Fargo into 2016 for several reasons: 1) a safe haven stock in a choppy, uncertain time period; 2) some benefit from acquisitions from GE Capital; 3) continued growth in several other areas – investment banking, credit cards, and payments; and 4) continued sizable capital return. 

  • [By Chris Dier-Scalise]

    Among the brands being sold were Alcoa Corporation (NYSE: AA) and Ford Motor Company(NYSE: F), which both paid out dividends in December. The financial and oil sectors also experienced a sell-off to finish 2016. Wells Fargo & Co (NYSE: WFC) and Citigroup Inc (NYSE: C) were net sold as each reached new year-to-date highs and investors unloaded ConocoPhillips (NYSE: COP) and Chevron Corporation (NYSE: CVX) as their prices normalized with the rise in the price of oil.

  • [By Ben Levisohn]

    Big banks like JPMorgan Chase (JPM), Wells Fargo (WFC), and Bank of America (BAC) have surged more than 20% during the past three months–causing many investors to doubt the possibility for further gains. I’m note one of them–after my disastrous financials call last year, I’m bullish on them in 2017–and neither is Morgan Stanley’s Betsy Graseck, who remains Overweight the big banks, despite their big gains. She explains why:

  • [By Ben Levisohn]

    Bank stocks have had quite a run since Donald Trump’s 2016 presidential election victory–such a run, in fact that Baird’s David George and team worry that most of the benefits of “potential improvement in macro growth, regulatory relief, and corporate tax reform” seem priced into their stocks. They recommend investors “selectively reduce bank exposure” but still like Wells Fargo (WFC), which they call a “top buy idea.” They explain why:

Top Canadian Stocks To Buy For 2018: Nu Skin Enterprises Inc.(NUS)

Advisors’ Opinion:

  • [By Scott Rubin]

    Stock gainers included Mercadolibre Inc (NASDAQ: MELI), up almost 14 percent, and Nu Skin Enterprises, Inc. (NYSE: NUS), which added 12 percent. The positive gains in both stocks were due to strong earnings reports. Shares of Liberty Interactive Group (NASDAQ: QVCA) plunged almost 22 percent on Friday due to disappointing sales growth in its fiscal second quarter. Pharmaceutical giant Bristol-Myers Squibb Co (NYSE: BMY) lost 16 percent after a disappointing study involving its Opdivo drug.

  • [By Roberto Pedone]

    Nu Skin Enterprises (NUS) is a direct selling company, which develops and distributes personal care products and nutritional supplements that are sold under the Nu Skin and Pharmanex brands. This stock closed up 5.4% at $92.96 in Monday’s trading session.

    Monday’s Volume: 2 million

    Three-Month Average Volume: 900,802

    Volume % Change: 85%

    From a technical perspective, NUS ripped higher here right above some near-term support at $85 with heavy upside volume. This move pushed shares of NUS into breakout and new 52-week-high territory, since the stock took out some near-term overhead resistance levels at $88.20 to $89.69. This move also pushed shares of NUS above the upper-end of its recent range that saw the stock trend between $82 to just above $89.

    Traders should now look for long-biased trades in NUS as long as it’s trending above support at $85 and then once it sustains a move or close above Monday’s high of $93.33 with volume that this near or above 900,802 shares. If we get that move soon, then NUS will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $100 to $105.

  • [By Craig Jones]

    Nu Skin Enterprises, Inc. (NYSE: NUS) is trading sharply higher on Friday, but options traders are buying puts in the name, said Jon Najarian. Traders were buying the June 50 puts and they paid around 6 percent for them, so they don't see much upside in Nu Skin Enterprises, explained Najarian. He followed the trade and he is planning to hold the position for a month.

  • [By Ben Levisohn]

    Citigroup’s Beth Kite calls Nu Skin Enterprises’ (NUS) earnings and guidance “awfully disappointing.” She explains why:

    “Frustrating” Describes 4Q15 & 2016 Guidance:Nu Skin (i) reported 4Q15 EPS of $0.62, 11 cents below consensus and us, and (ii) lowered 2016 EPS guidance, from $3.25-$3.40 to $2.40-$2.60.Nu Skin had three LTO’s in 4Q152 succeeded and 1 failed. The failure had far less to do with the product than with the sales strategy…

    Is Guidance Too Conservative or Is It Really This Bad? We get that Me failed to sell well in South Korea with the 12-month cartridge commitment. But given the strength in reps globally, the strength of Youth from its two LTOs in 2H15, and good results from Me when sold in Japan without the 12-month commitment, we wonder if guidance is aggressive to the downside. Indeed, the word “conservative” was said a lot by mgmt on the brief earnings call when describing guidance revisions.

    Maintaining Buy: While we now have less confidence in mgmt, from an external perspective, to forecast its results accurately, and from an internal perspective, to course correct quicklyi.e., why didn’t they drop the 12-month plan for Me in South Korea when it so obviously wasn’t workingwe are still confident in Youth & Me. The rep growth in South Asia/Pacific from Youth in 3Q led to better 4Q sales than we’d expected, Youth’s Americas LTO in 4Q drove lc sales up 26% YoY, and Me not only sold through in Japan in 4Q but also drove reps higher. We imagine that investors may have little patience or confidence in Nu Skin for a while, understandably. But the bar seems set fairly low now, so we are cautiously optimistic that Nu Skin can dig itself out of this hole as we go through 2016 and Me & Youth roll out more fully.

    Shares of Nu Skin have tumbled 13% to $27.31 at 2:11 p.m. today.

Top Canadian Stocks To Buy For 2018: Valeant Pharmaceuticals International Inc(VRX)

Advisors’ Opinion:

  • [By Kumar Abhishek]

    Shares of specialty pharma company Valeant Pharmaceuticals Intl Inc(NYSE:VRX)have tanked more than 20% in last two trading sessions, breaching the support from the 50 day SMA, after the Laval,Quebec-based company reported its Q4 and FY 2016 earnings on Tuesday, before the market opened. While the earnings itself were better than expected, the guidance for FY 2017 didn’t go down well with investors and wall street, earning the company multiple price target cuts. Valeant reported an adjusted profit of $1.26 a share against analysts’ estimateof $1.21. This was Valeant’s first beat in a long time. Even on the revenue front, the company reported better than expected results. Initially, the stock gained on the report of an earnings beat. However, once the guidance figures came in, the stock tanked. In our earnings preview of Valeant, we had said that the adjusted EBITDA guidance for 2017 will be the key driver of VRX stock after the earnings.

  • [By Benzinga News Desk]

    Just days after Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares took a steep tumble below the $11 level, the stock is almost back to an important level at $12: Link

  • [By Ashley Moore]

    The current rally of Valeant Pharmaceuticals International Inc. (NYSE: VRX) is being driven by two things. While investors are viewing these two catalysts as bullish, they are really just temporary solutions.

  • [By Casey Wilson]

    As disgraceful as Mylan’s pricing strategy may be, this next pharmaceutical firm is hated even more – and makes our list for the second year in a row…

    Most-Hated Companies 2016 No. 1: Valeant Pharmaceuticals International Inc. (NYSE: VRX)

    The troubled pharmaceutical company is deeply loathed by both consumers and investors alike.

Top 5 Canadian Stocks To Invest In Right Now

Canadian Prime Minister Justin Trudeau promised he would implement massive changes to Canada marijuana laws. And when he does, it will create a new and booming economy.

If Canada places a “sin tax” of 50% on recreational marijuana sales, the country could make $5 billion annually, according to a CIBC World Markets report.

Currently, only medical marijuana is legal in Canada.

But an overwhelming amount of Canadians support legalizing recreational marijuana…

According to a poll conducted in the summer of 2016, 43% of the 1,000 Canadians surveyed supported legalizing recreational marijuana. Also, 26% of those surveyed somewhat supported legalizing recreational marijuana.

Only 17% were opposed, and 9% were somewhat opposed.

Top 5 Canadian Stocks To Invest In Right Now: Nu Skin Enterprises Inc.(NUS)

Advisors’ Opinion:

  • [By Scott Rubin]

    Stock gainers included Mercadolibre Inc (NASDAQ: MELI), up almost 14 percent, and Nu Skin Enterprises, Inc. (NYSE: NUS), which added 12 percent. The positive gains in both stocks were due to strong earnings reports. Shares of Liberty Interactive Group (NASDAQ: QVCA) plunged almost 22 percent on Friday due to disappointing sales growth in its fiscal second quarter. Pharmaceutical giant Bristol-Myers Squibb Co (NYSE: BMY) lost 16 percent after a disappointing study involving its Opdivo drug.

  • [By Craig Jones]

    Nu Skin Enterprises, Inc. (NYSE: NUS) is trading sharply higher on Friday, but options traders are buying puts in the name, said Jon Najarian. Traders were buying the June 50 puts and they paid around 6 percent for them, so they don't see much upside in Nu Skin Enterprises, explained Najarian. He followed the trade and he is planning to hold the position for a month.

  • [By Ben Levisohn]

    Citigroup’s Beth Kite calls Nu Skin Enterprises’ (NUS) earnings and guidance “awfully disappointing.” She explains why:

    “Frustrating” Describes 4Q15 & 2016 Guidance:Nu Skin (i) reported 4Q15 EPS of $0.62, 11 cents below consensus and us, and (ii) lowered 2016 EPS guidance, from $3.25-$3.40 to $2.40-$2.60.Nu Skin had three LTO’s in 4Q152 succeeded and 1 failed. The failure had far less to do with the product than with the sales strategy…

    Is Guidance Too Conservative or Is It Really This Bad? We get that Me failed to sell well in South Korea with the 12-month cartridge commitment. But given the strength in reps globally, the strength of Youth from its two LTOs in 2H15, and good results from Me when sold in Japan without the 12-month commitment, we wonder if guidance is aggressive to the downside. Indeed, the word “conservative” was said a lot by mgmt on the brief earnings call when describing guidance revisions.

    Maintaining Buy: While we now have less confidence in mgmt, from an external perspective, to forecast its results accurately, and from an internal perspective, to course correct quicklyi.e., why didn’t they drop the 12-month plan for Me in South Korea when it so obviously wasn’t workingwe are still confident in Youth & Me. The rep growth in South Asia/Pacific from Youth in 3Q led to better 4Q sales than we’d expected, Youth’s Americas LTO in 4Q drove lc sales up 26% YoY, and Me not only sold through in Japan in 4Q but also drove reps higher. We imagine that investors may have little patience or confidence in Nu Skin for a while, understandably. But the bar seems set fairly low now, so we are cautiously optimistic that Nu Skin can dig itself out of this hole as we go through 2016 and Me & Youth roll out more fully.

    Shares of Nu Skin have tumbled 13% to $27.31 at 2:11 p.m. today.

Top 5 Canadian Stocks To Invest In Right Now: NEW GOLD INC.(NGD)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market lost ground on Monday, sending major market benchmarks lower by more than half a percentage point. The Dow lost its grip on the 20,000 mark in the wake of concerns about economic growth and new U.S. immigration policy, and some believe that the broader geopolitical climate could have a negative impact on global commerce that in turn could start affecting multinational corporations’ business prospects. In addition, bad news from some individual companies weighed on the markets, and Transocean (NYSE:RIG), Rite Aid (NYSE:RAD), and New Gold (NYSEMKT:NGD) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

Top 5 Canadian Stocks To Invest In Right Now: Encana Corporation(ECA)

Advisors’ Opinion:

  • [By Money Morning News Team]

    Canada-based Encana Corp. (NYSE: ECA) was the eighth top oil company stock in 2016, with a 131% gain over the year. ECA and its subsidiaries focus on developing, exploring, producing, and marketing natural gas, liquefied natural gas, and oil in North America.

  • [By Paul Ausick]

    Encana Corp. (NYSE: ECA) is rated Buy with an unchanged price target of $16. The EPS estimate for 2017 was lowered from $0.42 to $0.34, and the 2018 estimate was also lowered, from $1.47 to $1.28. The shares ended the weekat $11.44, in a 52-week range of $4.90 to $13.85. The consensus 12-month price target is $14.95.

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Vodafone Group (VOD) , Schlumberger (SLB) , Encana (ECA) , Arconic (ARNC) and AdvanSix (ASIX) .

    Cramer was bearish on U.S. Silica Holdings (SLCA) .

Top 5 Canadian Stocks To Invest In Right Now: Valeant Pharmaceuticals International Inc(VRX)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Bond prices were much lower early in the day, with yields up by nearly 10 basis points. But fixed income has rallied back (reducing the drop by half on the day). Valeant Pharmaceuticals (VRX) , more weakness. Large pharma lower, led by Eli Lilly (LLY) . Old tech lags, with International Business Machines (IBM) , Intel (INTC) , Cisco Systems (CSCO) and Microsoft (MSFT) all lower. Media roughed up a bit (CBS (CBS) and Comcast (CMCSA) ). The Ugly
    Gold down another $23 to $1,188 (SPDR Gold Trust ETF (GLD) down $2.25). Urban Outfitters (URBN) down $5. NOTE: There will be no “Takeaways” today!   Happy Thanksgiving. Position: Long GLD small, SDS large, JCP large; short SPY, CSCO, CAT small, IWM, TLT small.

  • [By Chris Lange]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) second-quarter results also are scheduled for Tuesday. The consensus forecast is $2.24 billion in revenue and earnings per share (EPS) of $0.97. Shares were last seen at $15.13. The 52-week range is $8.31 to $32.74.

  • [By Lisa Levin]

    Healthcare shares rose by 1.68 percent in the US market on Thursday. Top gainers in the sector included Sangamo Therapeutics Inc (NASDAQ: SGMO), Valeant Pharmaceuticals Intl Inc (NYSE: VRX), and Tenet Healthcare Corp (NYSE: THC).

  • [By Paul Ausick]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped about 2.7% Tuesday, to post a new 52-week low of $10.35 after closing at $10.64 on Monday. The stock’s 52-week high is $38.50. Volume was nearly equal to the daily average of around 18.6 million shares. The battered drug maker completed a $1.1 billion bond tender offer as investors couldn’t wait to cash out.

  • [By Paul Ausick]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped about 2% Friday to post a new 52-week low of $9.44 after closing Thursday at $9.63. The stock’s 52-week high is $38.50. Volume of nearly 15 million shares was about 25% below the daily average of around 19.5 million. The stock is on track to post a gain of around 0.5% for the day following an offer from Fresenius SE to acquire Akorn. Barron’s suggests that investors must believe there’s a buyer for anything, so why not Valeant?

Top 5 Canadian Stocks To Invest In Right Now: Prestige Brand Holdings Inc.(PBH)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Castor believes the cash has disappeared into working capital, which has grown from 23% to more than 50% since 2008. Comparable company PrestigeBrand (PBH) uses 11%; Unilever(UL) and Colgate-Palmolive(CL) far less.